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In June 2018, the European Monitoring Centre for 
Drugs and Drug Addiction (EMCDDA) published 
the European drug report 2018: trends and 
developments.1 This report provides a snapshot 
of the latest drug trends across the 28 European 
Union (EU) member states, Norway and Turkey. 
Across Europe (EU 28, Turkey and Norway), drug 
availability is high and in some areas appears to 
be increasing. Latest figures show more than one 
million seizures of illicit drugs in 2016. Over 92 
million adults in the EU (15–64 years) have tried 
an illicit drug in their lifetime and an estimated 1.3 
million people received treatment for illicit drug 
use in 2016.2
In Ireland, the number of people aged 15–64 years reporting 
that they used illicit drugs in their lifetime has risen from 2  
in 10 in 2002/3 to 3 in 10 in 2014/15. Cannabis remains the  
most commonly used illicit drug among this group, followed 
by MDMA and cocaine. A total of 9,227 cases presented for 
treatment in 2016. 
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In brief
Community organisations working in disadvantaged 
areas contribute to the democratic process by giving 
a voice to the most marginalised and by building the 
capacity of citizens to organise and participate in 
decision-making around the issues that affect them. 
Collective endeavour and empowerment are the mechanisms 
used to achieve social change and foster full, active 
participation in social and economic life. This contribution has 
been recognised in several Irish social and economic policy 
documents. The 2007 National action plan for social inclusion 
2007-2016 (NAPinclusion) identified a number of innovative 
actions under a special ‘Communities’ category, which were 
seen as key to achieving reductions in consistent poverty. The 
concepts of ‘active inclusion’ in the revised NAPinclusion for 
2015-2017 and an ‘integrated framework for social inclusion’ in 
the Programme for Government 2016 both depend on active 
community engagement. 
Reducing harm, supporting recovery: a health-led response 
to drug and alcohol use in Ireland 2017‒2025 underlines the 
importance of strengthening the capacity of communities to 
respond to problem drug use and emphasises the need for 
meaningful involvement of service users and their families in the 
planning, design and delivery of effective services. Community 
development, community-based management of health and 
education services, and involvement in cultural activities 
are vital parts of local life, particularly in areas affected by 
socioeconomic disadvantage, marginalisation and exclusion. 
These are the areas most impacted by problem drug use, a fact 
recognised by the framing of successive national drugs strategies 
within the context of social inclusion policy. Community-based 
organisations working in the drugs area deliver vital services at 
the local level, represent the interests and concerns of residents, 
and provide knowledge essential for the development of 
effective responses at the national level. 
This issue of Drugnet Ireland includes a report of a conference 
organised by the Clondalkin Drug and Alcohol Task Force 
(CDATF). While recognising the important role that community-
based organisations have in delivering services throughout 
successive drugs strategies, participants in the conference also 
expressed concern that decision-making had become more 
centralised and that the value of partnership needs greater 
acknowledgement and concrete support. In the last issue 
we looked at the effect of economic recession on illicit drug 
markets. Ireland departs slightly from European norms, possibly 
as a result of emigration trends. Nevertheless, the connection 
between difficult economic times and increased use of drugs 
in the population is well established. While the impact of the 
recession on drug services has not been rigorously calculated, it 
would be fair to say that the same economic factors that led to 
increasing demand on services have also resulted in a reduced 
capacity to meet this demand because of decreased funding. It 
is important that all stakeholders recognise these difficulties and 
take advantage of all opportunities to discuss them frankly and 
find new ways to develop and strengthen partnership through 
the current drugs strategy.
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Speaking about the latest report, Minister of State for  
Health Promotion and the National Drugs Strategy,  
Catherine Byrne said: 
The latest European drug report highlights the challenge 
of illicit drug use for Ireland and for Europe in general. 
The Department of Health will use the data gathered from 
across Europe to inform the ongoing implementation of 
our national drugs strategy, Reducing harm, supporting 
recovery. In particular, we must continue to be vigilant 
in responding to the emergence of new psychoactive 
substances. I therefore welcome the 75 per cent reduction 
in the use of new psychoactive substances by young adults 
in Ireland from 6.7 per cent in 2010/11 to 1.6 per cent in 
2014/15. The high number of drug related poisoning deaths 
every year (350 people in 2015) greatly concerns me and 
we want to reduce this number. One public health measure 
to specifically address heroin related deaths (82 in 2015) is 
the establishment of a pilot supervised injecting facility in 
Dublin city centre in 2018.
The situation described in the European drug report is 
presented below under a series of headings. The EMCDDA 
used the most recent data available to provide aggregate 
figures. While data on some indicators, such as treatment 
demand, are supplied annually, the year of the most recent 
prevalence data can vary. 
Cocaine
European situation
• The cocaine market in Europe is buoyant with a greater 
number of seizures and higher purity, possibly associated 
with rising production in Latin America. Further evidence 
of increased use comes from municipal wastewater 
analysis in several cities.
• Around 2.3 million young adults (15–34 years) have used 
cocaine in the last year across Europe. 
• There has been an increase in Europe in the number 
of first-time entrants to drug treatment services with 
cocaine as a main problem drug. 
• An estimated 8,300 clients entered treatment for 
primary crack cocaine use in 2016. 
Irish comparison
• In Ireland, the most recent general population survey in 
2014–15 shows that 2.9 per cent of 15–34-year-olds used 
cocaine in the last year, which had not changed since 
the 2010/11 survey. This is lower than the corresponding 
figure for the United Kingdom (UK) (4%) but roughly the 
same as Denmark, France and the Netherlands. Only 
these five countries report last-year prevalence of 
cocaine use among young adults of 2.5% or more.3
• Since 2014, there has been a steady increase in the 
proportion of new cases for treatment reporting cocaine 
as a main problem drug in Ireland, rising from a low of 
297 cases in 2013 to 568 cases in 2016. 
• In 2016, some 11.3% (112) of cocaine cases reported  
crack as their main problem drug, an increase from  
9.1% (81) in 2010.
Cannabis: availability and use
European situation
• Cannabis remains the most widely used illicit drug in 
Europe, its prominence evident in data on prevalence, 
drug law offences, seizures, and new treatment demand. 
• The EMCDDA estimates that 14% of young Europeans 
(15–34 years) used cannabis in the last year.
• Cannabis is responsible for the greatest share (45%) of 
new entrants to treatment, with numbers rising from 
43,000 cases in 2006 to 75,000 in 2016.
• In 2016, some 763,000 seizures of cannabis products 
were reported in the EU.  
Irish comparison
• Cannabis is also the most widely used illicit drug in 
Ireland, which is evident in prevalence, seizures, and  
new treatment demand.
• The 2014/15 general population survey reported that 
14% of young adults (15–34 years) used cannabis in the 
year prior to the survey, similar to Europe. This is the 
same prevalence as the European average for this age 
group and below that of Spain (17%), France (21%) and the 
Netherlands (16%), but slightly above that of the UK (12%).
• Cannabis is responsible for 41% of new cases presenting 
for treatment, with numbers rising from 1,338 in 2010  
to 1,452 in 2016.
• Between 2007 and 2015, the number of illicit drug 
seizures in Ireland has decreased. Cannabis seizures have 
also decreased over this time, but they remain the most 
commonly seized type of drug in Ireland.
• The 2014/15 ESPAD survey reported that 18.9% of 
15–16-year-old students had used cannabis during their 
lifetime. This places Ireland slightly above the EU average 
of 16.5%.3 
New psychoactive substances detected
European situation 
• Data on new psychoactive substances (NPS) are based on 
notifications by member states to the EU Early Warning 
System (EWS). In 2017, some 51 new substances were 
reported for the first time (66 in 2016). By the end of 
2017, the EMCDDA was monitoring more than 670 NPS, 
compared with around 300 monitored in 2013. Over 50% 
of the substances currently being monitored were still 
detected on Europe’s drug market.
• Almost 70% of new substances identified through the EU 
EWS were detected in the last five years.
• In 2016, almost 71,000 seizures of NPS were reported 
through the EU EWS. Together, synthetic cathinones and 
synthetic cannabinoids accounted for almost 80% of 
all seizures and 80% of all quantities of new substances 
seized in 2016.
• Synthetic cannabinoids were the most frequently seized 
NPS in 2016, with just over 32,000 seizures reported.  
In total, 118 synthetic cathinones have been identified 
since 2005, with 14 reported for the first time in 2016,  
a decrease from the 31 reported in 2014. 
• Overall, 38 new opioids have been detected on Europe’s 
drug market since 2009 — including 13 reported for the 
first time in 2017. 
European drug trends continued
4
dr
ug
ne
t I
R
EL
AN
D
   
   
Is
su
e 
66
 |  
Su
m
m
er
 2
0
18 Irish comparison
• A prevalence estimate of opioid use in the Republic of 
Ireland in 2014, calculated using an analysis of four data 
sources, was between 18,720 and 21,454.5 
• The estimates of prevalence of opioid use for Dublin in 
2014 were 13,458 opioid users. The corresponding figure 
for 2006, the last time the study was undertaken, was 
14,909. The prevalence for the rest of Ireland (excluding 
Dublin) was estimated to be 5,530, also a slight decrease 
from 2006.
• Opiates (mainly heroin) were the most common main 
problem drug reported by cases entering treatment 
in 2016. There were 4,202 cases (46.9%) in 2016, a 
continuation of the steady decrease in the proportion of 
the total number entering treatment in recent years. 
• Between 2007 and 2010, opiates (mainly heroin) were 
the main problem drug reported by new entrants, but 
opiates were superseded by cannabis in 2011, and this 
trend continues with one-quarter of new cases in 2016 
reporting heroin use.
• Methadone (alone or with another drug) was implicated 
in more than one-quarter of poisoning deaths and 
continues to be the opiate most commonly implicated in 
poisoning deaths. In 2015, there were 86 deaths where 
methadone was implicated, compared with 98 deaths 
in 2014. This is compared to a peak in 2011, when there 
were 119 deaths where methadone was implicated.
• In 2015, there were 82 deaths where heroin was 
implicated, compared with 90 in 2014.  
Further reading 
Accompanying the European drug report 2018 are 
Perspectives on drugs (PODs), online interactive articles 
providing insights into specific issues in the drugs field. 
A number of these PODs have been updated and were 
published alongside the report.  
Brian Galvin
1 European Monitoring Centre for Drugs and Drug Addiction 
(2018) European drug report 2018: trends and developments. 
Luxembourg: Publications Office of the European Union.  
https://www.drugsandalcohol.ie/29135/ 
2 For further information, visit  
http://www.emcdda.europa.eu/edr2018 
3 Taylor K, Babineau K, Keogan S, Whelan E and Clancy L (2016) 
ESPAD 2015: European Schools Project on Alcohol and  
Other Drugs in Ireland. Dublin: Department of Health.  
https://www.drugsandalcohol.ie/26116/
4 European Monitoring Centre for Drugs and Drug Addiction  
and Eurojust (2016) New psychoactive substances in  
Europe: legislation and prosecution — current challenges  
and solutions. Luxembourg: EMCDDA–Eurojust joint  
publication, Publications Office of the European Union.  
https://www.drugsandalcohol.ie/26385/ 
5 Hay G, Jaddoa A, Oyston J, Webster J, Van Hout MC and  
Rael dos Santos A (2017) Estimating the prevalence of 
problematic opiate use in Ireland using indirect statistical 
methods. Dublin: National Advisory Committee on Drugs  
and Alcohol. https://www.drugsandalcohol.ie/27233/
• The EMCDDA estimates that 2.2 million young adults (15–
34 years, or 1.8% of this age group) used MDMA/ecstasy 
in the last year. National estimates vary considerably with 
the Netherlands highest at 7.4%. 
• While consumption levels of NPS are low overall in Europe, 
in a 2016 EMCDDA study over two-thirds of countries 
reported their use by high-risk drug users.4 In particular, 
the use of synthetic cathinones by opioid and stimulant 
injectors has been linked to health and social problems.
 
Irish comparison
• In 2010, more than 200 individual substances were 
controlled under the Misuse of Drugs Act 1977, and the 
Criminal Justice (Psychoactive Substances) Act 2010 was 
passed to prohibit the supply of harmful NPS. While the 
Court of Appeal effectively annulled earlier declaration 
orders banning numerous substances, the Misuse of Drug 
(Amendment) Act 2015 was introduced to control these 
substances in Ireland. 
• The 2014/15 general population survey reported last-
year prevalence of ecstasy of 4% for young adults (15–34 
years), a significant increase from 0.9% recorded in the 
2010/11 survey.
• Last-year prevalence of NPS, such as herbal smoking 
mixtures, party pills or herbal highs, or powders such as 
cathinones, was included as a drug category for the first 
time in the 2010/11 general population survey. In contrast 
to trends observed with other illicit substances, data 
from the 2014/15 study demonstrate a reduction in the 
use of NPS by young adults, from 6.7% to 1.6%. Last-
month prevalence was less than 1% for respondents aged 
15–64 years.
• There were 72 entrants to treatment in 2016 for whom an 
NSP was the main problem drug. The proportion of cases 
treated for this type of drug peaked in 2010 at 2.5% of 
all treatment episodes, but dropped to 0.2% in 2012 and 
has increased to represent 0.8% in 2016. 
• In 2015, MDMA (alone or with other drugs) was implicated 
in eight deaths compared with 15 such deaths in 2014. 
• In Ireland, 4.4% of 15–34-year-olds had used MDMA in 
the past year. Ireland is second after the Netherlands in 
Europe for prevalence of this drug. 
Opioids (mainly heroin)
European situation
• There were an estimated 1.3 million high-risk opioid users 
in Europe in 2016.
• In 2016, use of opioids was reported as the main reason 
for entering specialised drug treatment by 177,000 clients 
or 37% of all those entering drug treatment in Europe. 
Of these, 35,000 were first-time entrants, 83% of whom 
reported heroin as their primary drug. 
• It is estimated that at least 7,929 overdose deaths, 
mainly involving opioids, occurred in the EU in 2016. As in 
previous years, the UK (34%) and Germany (15%) together 
account for around one-half of the European total.
• Between 2002 and 2014, the quantity of heroin seized 
within the EU halved, from 10 to 5 tonnes, and has 
stabilised in recent years. A total of 4.3 tonnes were 
seized in 2016.
European drug trends continued
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• Government policies, particularly those linked to 
austerity, have resulted in negative outcomes for  
people living in the area. 
• There has been a negative impact on users and their 
families as a result of a policy shift in Government 
towards seeing drug use as an individual behavioural 
issue. 
• The task force was operating in an environment where 
the centralisation of decision-making had increasingly 
become the norm. This served to undermine the 
community-based interagency and partnership approach 
that had been a central feature of their way of working 
when originally established.  
As well as the report, CDATF took into account the broader 
context of the new national drug and alcohol strategy, and an 
assessment of the existing strengths and assets of the work 
of the task force, its partners and their community. This was 
done through stakeholder consultations and working group 
discussions. To facilitate the process, CDATF engaged Brian 
Dillon of Nexus Research Cooperative. At the conference, he 
described the process undertaken in developing the strategy. 
He emphasised the need to ‘reclaim community development’ 
and for joint decisions on how best to address the causes 
and consequences of drug use at a community level, rather 
than waiting for ‘central instructions’ from Government. He 
described the approach taken by CDATF in their strategy as  
‘a courageous stand to make’.
The overall mission statement of the strategy is: 
To re-establish and strengthen the role of the community 
in tackling the causes and consequences of drug and 
alcohol misuse; facilitate the re-establishment of 
meaningful and effective partnerships; and support the 
development of a holistic approach to dealing with both 
the causes and consequences of drug and alcohol misuse 
in the CDATF area.
POLICY AND LEGISLATION 
Reclaiming 
community 
development
On 26 March 2018, Clondalkin Drug and Alcohol Task Force 
(CDATF) held a conference on ‘Reclaiming community 
development as an effective response to drug harms, policy 
harms, poverty and inequality’.1,2 The conference marked the 
launch of the CDATF 2018–2025 strategic plan of the same 
title. Minister Catherine Byrne TD launched the strategy and 
welcomed the approach taken, noting that it reflects ‘many of 
the themes’ running through the national strategy. 
Central to the conference and the strategy is the message 
that community development has a critical role to play in the 
effective delivery of the local and national drug strategies. 
There were calls for both a reversal of the perceived trend 
over recent years towards a more centralised approach 
to decision-making in the drugs field and a return to more 
meaningful ways of working in partnership. 
CDATF strategy
CDATF took a systematic approach to the development of 
their new strategy. It is grounded in the findings of a 2015 
report published by the task force on Outcomes: drug harms, 
policy harms, poverty and inequality.3 Among the findings 
identified as having had particular influence over the direction 
of the strategy are:  
• Drug and alcohol misuse cannot be dealt with in isolation 
as they are inextricably linked with other factors 
associated with poverty and inequality. 
Attending the launch of the CDATF 
2018–2025 strategic plan (from L-R): Lara 
Fox (CDATF administrator), Jennifer Clancy 
(CDATF coordinator), Tara Deacy (CDATF 
prevention officer), Catherine Byrne TD 
(Minister of State for Health Promotion 
and the National Drugs Strategy), Ray 
McGrath (CDATF chairperson) and Sandra 
Mullins (previous CDATF coordinator) 
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18 She argued that while community development is not 
mentioned specifically in the new strategy, the same 
principles underpin the current national strategy and 
that the community ‘need to reclaim it’. Similarly, she 
noted that unlike in previous strategies, the link between 
broader social and economic issues and drug use is not 
made in the current strategy.
• Graham Atwell, an associate fellow at the Warwick Institute 
for Employment Research in the University of Warwick, 
spoke about measuring outcomes and demonstrating the 
value of community development approaches.
• There was also a screening of a short film From Here 
by THEATREclub, commissioned by CDATF. It illustrates 
the experiences of people trying to engage with State 
services and the perceived stigma attached to people 
living in certain communities.4
Concluding comment
The overall message from the day was that it was critical 
for a response to local drugs issues to be grounded in and 
supported by community development. This required all 
stakeholders to work together in a meaningful partnership and 
to take joint ownership of responses to the challenges faced. 
Lucy Dillon
1 Clondalkin Drug and Alcohol Task Force (2018) Clondalkin  
Drug and Alcohol Task Force strategic plan 2018–2025. 
Reclaiming community development as an effective response  
to drug harms, policy harms, poverty and inequality.  
Dublin: Clondalkin Drug and Alcohol Task Force.  
https://www.drugsandalcohol.ie/28841/ 
2 The presentations are available to view at  
https://www.clondalkindrugstaskforce.ie/
3 O’Gorman A, Driscoll A, Moore K and Roantree D (2016) 
Outcomes: drug harms, policy harms, poverty and inequality. 
Dublin: Clondalkin Drug and Alcohol Task Force.  
http://www.drugsandalcohol.ie/25577/
4  From Here by THEATREclub can be viewed here:  
http://www.theatreclub.ie/fromhere/
There are three strategic goals, each of which has its own set 
of objectives and outcome indicators. These goals are: 
• Dealing with the effects of drug and alcohol misuse
• Strengthening the role of the community in addressing 
the causes of drug and alcohol misuse
• Having a positive influence on mainstream services and 
contributing to more integrated responses 
They identify four core values that underpin this work: 
community development; person centred; human rights 
based; and evidence based. 
CDATF conference
As well as presentations by Minister Byrne and members of 
CDATF that focused on the new strategy, presentations were 
made on the conference theme more broadly:2 
• Paul Ginnell, director of the European Anti-Poverty 
Network, spoke about European policy and how it relates 
to the Irish community and voluntary sector.
• Joe Larragy, lecturer in social policy in Maynooth University, 
presented on the challenges of making partnership 
between the State and community/voluntary sector work. 
He described the history of social partnership in Ireland 
and how the community and voluntary pillar became part 
of this in 1996, until it was dissolved in 2009. Larragy argued 
that despite a lack of bargaining power, the community and 
voluntary pillar can still have influence over policy. They 
should develop their own ‘thoughtful policies’ that can 
then be latched onto by politicians or political parties in 
opportune policy windows.
• Anna Quigley of CityWide Drugs Crisis Campaign 
presented on the role of community participation in 
the past, present and future national drugs strategies 
and their structures. Quigley described how from the 
beginning that Irish national drug strategies have been 
grounded in the principles of community development. 
Community development continued
Report on penal 
reform and 
sentencing
Increased interest in penal reform and sentencing in Ireland 
has resulted in the publication of several reports.1,2,3,4 An 
updated report, which re-examined this subject, was 
published by the Joint Committee on Justice and Equality in 
May 2018.5 The report brings together existing evidence and 
the views of key stakeholder groups, such as the Irish Penal 
Reform Trust (IPRT), Victims’ Rights Alliance, Probation Service, 
Irish Prison Service, Jesuit Centre for Faith and Justice, Prison 
Officers’ Association, and Simon Communities of Ireland. The 
overall aim was to determine what the main issues were and to 
identify ‘specific actions’ to overcome them. The themes that 
emerged from the engagement with stakeholders resulted in 
several recommendations by the committee.
Prison numbers and conditions
Although daily prison populations in Ireland are average 
compared with our European counterparts, committal rates 
were viewed as high. Overcrowding was identified as an issue 
in some prison estates along with problems such as safety 
of offenders and staff, health and wellbeing. The committee 
recommended that prison numbers should be capped, and 
a Government strategy should be implemented to decrease 
the prison population by 50%. A ‘one size fits all’ was not 
considered suitable for a prison setting nor was the over-
reliance on closed prisons (p. 53). The committee urged that 
new prisons should be more flexible and utilise state-of-the-
art, community-based, semi-open facilities. 
The increase in female prisoners was viewed as dramatic. 
It was suggested that a possible way to reduce the number 
of females in prison was to provide step-down units post-
release. However, the committee recommended that a 
Housing First approach should be used instead. It was 
proposed that young people aged 18–24 years should be 
recognised as a distinct group that comes under the remit 
of the Irish Youth Justice Service and the Department of 
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Children and Youth Affairs. In addition, each youth detention 
centre should be paired with third-level and further 
education colleges. Finally, the committee called for an 
accommodation policy which should ensure that all prisoners 
are in single occupancy cells.
Complaints and inspections
The committee recommended that a mechanism for 
considering prisoner complaints should be set up as well  
as a complaints procedure. The group also called for 
legislation to provide for inspections in all detention places 
within the Irish justice system and for the immediate 
ratification of the optional protocol to the United Nations 
Convention against Torture.
Family/visitation
The influence of family and children was highlighted as a 
driving force for behaviour change. The committee believed 
that these relationships should be promoted and maintained 
during incarceration and post-release. Establishing mother 
and baby units would further promote and support child 
wellbeing and family life.
Addiction and mental health
The evidence provided indicated that a large proportion of 
committals presented with addiction or substance abuse 
(70%) and mental health issues. Access to rehabilitation 
services is vital and prisoners need to be aware of what they 
can access. Currently, prisoners experience extensive delays 
in accessing services. The committee urged that it was 
imperative that sufficient resources were provided to help 
address prisoners’ mental health needs. 
Although the committee welcomed violent and disruptive 
prisoner (VDP) units in the Midlands Prison, the establishment 
of VDP units across the prison estate was recommended. 
Moreover, prison staff require support regarding their 
wellbeing as well as appropriate compulsory training to allow 
them to manage and help prisoners with health problems. 
Problems, such as addiction, homelessness and reoffending, 
are not isolated events but are often interconnected and 
hence a multiagency intervention should be applied pre-  
and post-release.
Education, retraining and  
therapeutic approach
The main argument put forward by stakeholders was that a 
therapeutic instead of a punitive prison setting was more 
helpful in the rehabilitation of prisoners to society. The 
committee called for a similar model to be used in Ireland. 
Moreover, education and training facilities were viewed as 
necessary to enable prisoners to develop skills that will hold 
them in good stead upon release. The committee believed 
that an opportunity to locate units of therapy and education 
in Irish prisons exists; this approach has already been  
shown to be successful in other countries, for example,  
the Villabona project in Spain.
Health
Due to recent criticisms of how healthcare is managed in 
Irish prisons by the European Committee for the Prevention 
of Torture, the committee recommended that the Health 
Information and Quality Authority (HIQA) should carry out a 
review of prison healthcare and that additional resources 
need to be assigned to allow the Health Service Executive to 
provide prison healthcare.
Solitary confinement and extended lock-up
Solitary confinement and extended lock-up should be 
phased out. The committee called on the Government to 
facilitate the passage of the Private Members’ Bill entitled 
the Prisons (Solitary Confinement) (Amendment) Bill 2016 
without delay. This Bill provides a definition of solitary 
confinement and provides that prisoners should not be held 
for 15 days or more in solitary confinement. 
Sentencing and remission /  
early release policies
Greater emphasis should be placed on alternatives to 
imprisonment, such as community-based sanctions and 
non-custodial sentences. As many as 50% of committals 
are the result of unpaid fines, despite the existence of the 
Fines (Payment and Recovery) Act 2014, which allows for 
alternatives such as recovery orders and earnings orders. The 
committee has called for a review to determine whether these 
provisions are being used or not. They also contend that the 
payment threshold is too high (€100) and should be removed 
and the length of time taken to pay fines should be returned 
to two years, as stated in the original Fines Act 2010.
With regard to drug offences, the committee believed 
that non-custodial treatment options should be utilised 
more widely. Under current legislation, the court may 
place an offender under supervision of a named person 
or organisation for a certain period of time, and/or refer 
him/her for treatment or further education/training. The 
committee has called for a review to determine why these 
options are not being utilised. They further call for the 
expansion of Garda diversion and community projects as 
additional alternatives to imprisonment.
The committee welcomed the Community Return Scheme, 
which is an incentivised scheme where participants receive 
supervised community service rather than staying in prison. 
This programme allows qualifying prisoners to be released 
early to carry out unpaid community work. Prisoners that 
pose no threat, have served between one and eight years in 
prison, and at least one-half of their sentence are eligible 
to participate. Thus far, this programme has been shown to 
be successful and the committee believed that it should be 
expanded to release more prisoners.
Spent convictions
Limitations of the Criminal Justice (Spent Convictions and 
Certain Disclosures) Act 2016 were highlighted and require 
immediate attention. Under this Act, circumstances such 
as being young, having an addiction or experiencing poverty 
are not considered as factors that may have influenced 
and/or resulted in criminal behaviour. In addition, although 
provisions exist for young people aged up to 18 years, none 
exist for those aged between 18 and 24 years. Moreover, the 
Act does not allow for the rehabilitation of offenders that 
have carried out more serious crimes.
Penal reform and sentencing 
continued
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continued
Homelessness
The committee proposed that a Housing First approach 
should be used such that prisoners upon release from 
prison are provided with their own home and adequate 
supports. This approach has been shown to result in higher 
reintegration into society and lower risk of reoffending.
Parole
The transformation of the current parole system into a 
statutory parole board independent of government control 
and which uses transparent and just decision-making 
processes was viewed as essential. 
Victims of crime
Rather than offenders paying a fine, a victim surcharge 
system was recommended by the committee, where 
offenders pay a surcharge to the victim. This charge would 
then go towards providing support to organisations that 
support victims.
Conclusion
The IPRT welcomed the recommendations of the committee, 
which it believed took into consideration many of the issues 
raised by the IPRT to the Oireachtas committee.6,7 Although 
progress has been made since the initial report in 2013,2 
clearly based on the evidence presented in the updated 
report, more work needs to be done. 
To that end, ‘the committee looks forward to working 
proactively and productively with the Minister to address 
issues in the penal system in the future’ (p. 3).5 
Ciara H Guiney
1 Thornton Hall Project Review Group (2011) Report of the 
Thornton Hall Project Review Group. Dublin: Department of 
Justice and Equality. https://www.drugsandalcohol.ie/15678/ 
2 Houses of the Oireachtas Joint Committee on Justice, Defence 
and Equality (2013) Report on penal reform. Dublin: Houses of 
the Oireachtas. https://www.drugsandalcohol.ie/19618/ 
3 Strategic Review Group on Penal Policy (2014) Strategic review 
of penal policy: final report. Dublin: Department of Justice and 
Equality. https://www.drugsandalcohol.ie/22657/
4 Joint Committee on Justice, Defence and Equality (2015)  
Report of the committee on a harm reducing and  
rehabilitative approach to possession of small amounts  
of illegal drugs. Dublin: Houses of the Oireachtas.  
https://www.drugsandalcohol.ie/24750/ 
5 Joint Committee on Justice and Equality (2018) Report on penal 
reform and sentencing. Dublin: Houses of the Oireachtas. 
https://www.drugsandalcohol.ie/28994/ 
6 Leogue J (2018) Report calls for range of prison reforms.  
Irish Examiner, 11 May 2018. Available online at:  
https://www.irishexaminer.com/ireland/report-calls-for-range-
of-prison-reforms-470508.html 
7 Irish Penal Reform Trust (2018) Press release: report on penal 
reform and sentencing. Dublin: Irish Penal Reform Trust.  
Available online at: http://www.iprt.ie/contents/3283 
Same crime: different 
punishment? 
Sentencing disparities 
between Irish and 
non-Irish nationals
A central view of justice in democratic societies is that 
people are regarded equally and respectfully and are 
not exposed to discrimination, directly or indirectly (p. 
1).1 An area of concern worldwide is the occurrence of 
discrimination centred on ethnic, cultural or social groups 
within the criminal justice system.2 Historically, Ireland has 
been associated with ‘mass emigration’ (p. 1).3 However, 
since the nineties and noughties, due to the economic 
downturn, this trend has been reversed and Ireland has 
become a multicultural society that is now home to many 
EU citizens.3 The change in Ireland’s population has similarly 
been reflected within the Irish criminal justice system. 
Hence, the study described here by Brandon and O’Connell 
is timely and aimed at determining whether racial bias was 
present in Irish sentencing practices between Irish and non-
Irish nationals.4 
Based on the findings of the literature review, attention was 
paid specifically to offences that involved theft and robbery 
and those that were subject to ethnic profiling, such as 
motoring and drug offences. The research question that was 
addressed was: Are non-Irish nationals receiving harsher 
sentences than Irish nationals for the same offence?
Methods
The data, which was collated by the Irish Prison Service, 
covered a 12-month period between 2015 and 2017. Table 1 
shows the prevailing characteristics of the prison population 
under examination. The final dataset comprised 35 offence 
categories.
Table 1: Summary of characteristics of participants examined
Protective factor Total Irish Non-Irish
Cases 11 158 9949 1209
Males 8691 7642 1049
Females 2467 2307 160
Age 17–90 years
Mean age 33.41 
(SD=10.43)
33.83 34.96
Source: Brandon and O’Connell, 2017, p. 113
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Discussion
Although the findings of this study could suggest the 
presence of a racial bias within the Irish criminal justice 
system, the authors contend that other reasons could be 
put forward to explain the outcomes found. For instance, 
non-Irish nationals may not have a clear understanding of 
the Irish justice system. An earlier admission of guilt can 
result in community punishment instead of imprisonment or 
a reduction in custodial sentence by up to one-third, which 
could result in shorter sentences. 
Additionally, how data are recorded may not be accurate. 
For example, the Irish Traveller community are deemed to 
be over-represented in the Irish criminal justice system; 
however, they are mainly invisible, in that any sentences 
received are included with the data for Irish nationals. 
Hence, the differences between Irish and non-Irish may 
be larger than this study shows. Likewise, some non-Irish 
residents and prisoners may in fact be British citizens, and 
hence may not be viewed as foreign at all. Some of those 
receiving custodial sentences for possession of drugs for 
sale or supply may not be resident in Ireland, yet the level of 
detail covered by this dataset does not cover this fact.
Limitations and future research
The authors acknowledged several limitations in the study. 
Although the number of cases and the timeframe of 
this study was a considerable strength for data analysis, 
the authors recognised that some factors could not be 
considered as they were not available, for example, mitigating 
and aggravating circumstances. With the aim of establishing 
a more in-depth picture of the link between ethnicity and 
sentencing, the authors have recommended that further 
research should consider including detailed measures of 
offence seriousness.
Conclusion
This is the first study to examine differences between 
Irish and non-Irish nationals within the Irish criminal 
justice system. It has demonstrated that even when other 
factors, such as gender and previous sentences, have been 
accounted for, non-Irish nationals received longer sentences 
than Irish nationals. The authors have recognised that this 
study is not without limitation; however, the results suggest 
that racial bias does occur in Ireland’s criminal justice system 
and further investigation of this area is justified. 
Ciara H Guiney
1 Shute S, Hood R and Seemungal F (2005) A fair hearing? Ethnic 
minorities in the criminal courts. London: Willan. 
2 Clark JW, Cramer RJ, Percosky A, Rufino KA, Miller RS and 
Johnson SM (2013) Juror perceptions of African American-  
and Arabic-named victims. Psychiatry, Psychology and Law, 
20(5): 781–94. 
3 Bracken DC (2015) Probation practice with non-Irish national 
offenders in the Republic of Ireland. Irish Probation Journal,  
12: 95–112. Available online at: http://www.probation.ie/en/PB/
Pages/WP16000152 
4 Brandon AM and O’Connell M (2017) Same crime: different 
punishment? Investigating sentencing disparities between  
Irish and non-Irish nationals in the Irish criminal justice  
system. British Journal of Criminology, azx080: 1–20.  
http://www.drugsandalcohol.ie/28629/
Results 
Non-Irish national representation
Across all offence categories, 10.84% of committals were 
non-Irish nationals. As shown in Table 2, cross-tabulation 
analyses indicated that although non-Irish nationals were 
under-represented in a range of offences, they were over-
represented in four offence categories: driving under the 
influence; having no vehicle insurance; theft; and possession 
of drugs for sale or supply to the value of <€13,000.
Nationality bias in sentencing
Independent t-tests were applied to determine whether 
mean sentence length received by non-Irish nationals 
differed from sentences received by Irish nationals. The 
results showed that Irish nationals received significantly 
longer sentences for assault and no road tax. Non-
Irish nationals received significantly longer sentences 
for estreatment of bail, using a vehicle without an NCT 
certificate, and failure to comply with a Garda. 
Regarding offences for possession of drugs for sale or 
supply to the value of <€13,000, although non-Irish nationals 
received sentences 10.95 months longer than Irish males, 
Cohen’s d was small (d=0.33). Similarly, a regression analysis 
by gender illustrated that sentences received by non-Irish 
males were 10.78 months longer than those received by Irish 
males (p=0.018).
Table 2: Under-representation and over-representation of non-
Irish nationals across different offence categories
Offence  
categories
Under-
represented
Over- 
represented
Attempted robbery ✔
Vehicle theft ✔
Criminal damage ✔
Robbery ✔
Parking fine offences ✔
Assault causing harm ✔
Intoxication in a public place ✔
Threatening behaviour in a 
public place
✔
Unlawful possession of drugs ✔
No television licence ✔
Driving under the influence ✔
No vehicle insurance ✔
Theft ✔
Possession of drugs for sale/
supply (to the value of <€13,000)
✔
Source: Brandon and O’Connell, 2017, p. 113
Impact of a previous custodial sentence
The authors examined the possibility that previous  
custodial sentences influenced sentencing outcomes;  
66.9% had a previous custodial sentence. No difference  
was shown for possession of drugs for sale or supply. 
However, non-Irish nationals received longer sentences  
for two offences: estreatment of bail and using a vehicle 
without an NCT certificate. 
Sentencing disparities continued
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reports and 
individualised 
justice: consistency, 
temporality and 
contingency
With the aim of decreasing the dependence by criminal 
justice systems on imprisonment, numerous reports have 
encouraged drawing on a wider array of alternatives to 
prison, for example, pre-sentence reports (PSRs). PSRs 
are requested by judges from probation officers after a 
defendant is found guilty and before sentencing. They 
contain in-depth information about the defendant, such 
as personal circumstances, background, ability to engage 
in rehabilitation, risk of reoffending, and may also provide 
guidance on sentencing and rehabilitation, which may or may 
not inform sentencing. Primarily, research has highlighted 
the importance of PSRs; however, although they are regularly 
used in Ireland, despite no statutory requirement to do so, 
the process involved is not clearly understood. 
This article presents the main findings of a study entitled 
Individualising justice: pre-sentence reports in the Irish 
criminal justice system, which was commissioned by the 
Probation Service to investigate the role of PSRs within the 
Irish criminal justice system.1,2 More specifically, this study:
• Investigated the circumstances in which pre-sentence 
reports are used by judges.
• Explored the construction of pre-sentence reports  
by probations officers and how they were interpreted  
by judges. 
• Explored how PSRs impact on sentencing (pp. 9–10).1 
Methodology
The study was mainly qualitative and utilised a range  
of methods:  
• Observation of probation interview practices (n=21), 
ranging from two to four per defendant
• Content analysis of pre-sentence reports from the 
District Court (n=5) and Circuit Court (n=4)
• Semi-structured interviews with probation officers (n=9) 
and judges (n=5)
Results
As shown in Table 1, three of the cases reviewed were related 
to drug offences. 
Probation officer perspectives
Due to the high association between sentence 
recommendations and actual sentencing outcomes, 
probation officers felt confident that their reports were  
well received in court. However, they were uncertain as  
to whether judges read the reports in full or whether  
judges and probation officers had a shared understanding  
of risk assessment.1
Judges perspectives
In the main, judges’ perceptions of PSRs and their part in 
sentencing was positive. They welcomed ‘clear direction’ 
from probation officers because their expertise was in the 
‘social’ area and risk assessment, which many judges did not 
understand (p. 110).1 Feelings towards the Probation Service 
was also positive. Judges believed that imprisonment could 
have a harmful impact and thus community sentences were a 
step towards rehabilitation. However, referral decisions were 
moderated due to knowledge that resources were lacking 
and the belief that cases needed to be prioritised.
Limitations
As acknowledged by the authors, although the information 
gleaned provided an increased understanding of PSRs and 
the process involved in Ireland, this study centred on one 
metropolitan area. It is already known that court practices 
and cultures and the use of PSRs and community sanctions 
differ throughout Ireland. Consequently, generalisability 
of the findings of this study to other areas is questionable. 
Additionally, a central characteristic of the five judges who 
participated in this study was that they were all advocates of 
PSRs and community sanctions. Hence, the beliefs reported 
may not be reflective of judges who are not inclined to use 
PSRs or community sanctions. It was understood from the 
initial design of the study that defendant perceptions of PSRs 
and the process would be sought using interviews. However, 
the length of time taken between requesting a PSR and 
sentencing made it challenging and impossible to follow-up 
the defendants. If this information had been collected, it 
would have added another dimension to the findings. 
Table 1: Overview of cases related to drug offences
Case Offence Sentence Length of time between report 
request and court sentence
CC02 Possession of drugs with intent to supply Suspended prison sentence 
(three years). No supervision
140 days
DC03 Unlawful possession of drugs (x2); 
 Possession of drugs with intent to supply
Adjourned supervision – seven 
months, then case struck out
215 days
DC04 Possession of drugs for the purpose  
of sale or supply;
Unlawful possession of drugs;
Possession of a knife
Suspended prison sentence 
(nine months)
198 days
Source: Carr and Maguire, 2017, pp. 59–602
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Attitudes to 
medicinal cannabis 
of patients with 
chronic pain 
Both nationally and internationally there is ongoing debate 
about the medical use of cannabis for a range of conditions. 
The attitudes to medicinal cannabis of a sample of Irish 
patients experiencing chronic pain are the subject of a new 
study.1 In a 2017 review on the topic by the Health Products 
Regulatory Authority (HPRA), the medical use of cannabis 
is defined as ‘a situation where a doctor prescribes or 
recommends the use of cannabis for treatment of a medical 
condition in a patient under his/her care’ (p. 9).2 The 
review found three medical conditions for which there was 
‘some scientific evidence to support the use of cannabis or 
cannabinoids as a medical treatment in patients who have 
failed available treatments’ (p. 16).2 
These were spasticity associated with multiple sclerosis; 
intractable nausea and vomiting associated with 
chemotherapy; and severe, refractory (treatment-resistant) 
epilepsy. Based on these findings, the Minister for Health 
established an access programme for cannabis-based 
treatments for people with any of the three approved 
medical conditions. However, the review found insufficient 
evidence to support the use of medicinal cannabis for other 
conditions, including chronic pain.3 Therefore, patients 
experiencing chronic pain fall outside the access criteria for 
the access programme. It is within this context that Rochford 
et al. carried out their study.1 
Methods
The aim of the study was to explore the attitudes of patients 
experiencing chronic pain towards medicinal cannabis. 
The research team used a questionnaire that gathered 
basic sociodemographic information, had 12 statements 
on the topic, and used a five-point Likert scale to assess 
the extent to which they agreed with each statement.4 
Data were collected from patients attending chronic pain 
clinics in University Hospital Limerick. While 96 surveys 
were completed, the overall response rate is not reported. 
Therefore, while the authors generalise their findings to ‘Irish 
patients experiencing chronic pain’, it is unclear whether the 
sample is representative of this population. 
Findings
Descriptive analysis was carried out on the data. The key 
findings were as follows. 
Cannabis use 
• 22.92% had tried cannabis before.
• 68.75% would try cannabis if it were prescribed for them. 
Legal status of cannabis 
• 86.46% agreed that cannabis should be legalised for 
medicinal purposes, and 88.54% agreed that it should 
be legalised for chronic pain. If legalised, 87.5% agreed 
that it should only be available through a consultant’s 
prescription. 
• A more general statement about the legal status of 
cannabis suggests that there is not as much support 
for a change in the law when it comes to the broader 
use of cannabis. Some 58.33% agreed that ‘the criminal 
status of cannabis should be abolished’. However, 
this statement is unclear as to whether it refers to 
the decriminalisation of the use of cannabis or the 
legalisation of cannabis itself.
Perceived health benefits
• 80.21% agreed with the broad statement ‘cannabis has 
health benefits when used appropriately’. 
Social acceptability of cannabis
• 73.96% agreed that it would be socially acceptable to use 
cannabis for medicinal purposes. 
Safety of cannabis
• 43.75% agreed with the statement that cannabis was a 
safe drug, with 42.71% responding ‘neutral’.
• 51.04% agreed with the statement ‘cannabis is safer than 
morphine’, with 43.75% responding ‘neutral’.
• 33.33% agreed that cannabis was addictive, with 43.75% 
responding ‘neutral’.
Pre-sentence reports continued
Conclusion
The authors concluded that PSRs play a vital but somewhat 
unrecognised part within the Irish criminal justice system. 
They allow two diverse professional groups, probation officers 
and judges, to communicate and interact. Despite differences 
in the philosophical underpinnings of these professions, they 
both appreciate the functionality of the PSR, formally in 
assisting judicial decision-making and informally by providing 
a pause in the process, which gives defendants a chance 
to engage, thus illustrating their ability and commitment to 
change. Nevertheless, as evidenced by this study, there were 
variations in how PSRs are utilised, which could be explained 
by inadequate policy and legislative guidance. 
As acknowledged by the authors, this study provided insight 
and further understanding of PSRs and the process involved 
in their utilisation from an Irish context. However, further 
research is required to address the limitations identified. 
Ciara H Guiney
1 Maguire N and Carr N (2017) Individualising justice: pre-
sentence reports in the Irish criminal justice system. Dublin: 
Probation Service. https://www.drugsandalcohol.ie/27967/
2 Carr N and Maguire N (2017) Pre-sentence reports and 
individualised justice: consistency, temporality and  
contingency. Irish Probation Journal, 14: 52–71.  
https://www.drugsandalcohol.ie/28303/
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1 Rochford C, Edgeworth D, Hashim M and Harmon D (2018) 
Attitudes of Irish patients with chronic pain towards medicinal 
cannabis, Ir J Med Sci. [Early online]  
https://www.drugsandalcohol.ie/28551/
2 Health Products Regulatory Authority (2017) Cannabis for  
medical use: a scientific review. Dublin: Department of Health. 
http://www.drugsandalcohol.ie/26784/
3 Dillon L (2017) Cannabis for medical use: a scientific review, Drugnet 
Ireland, 62: 9–10. https://www.drugsandalcohol.ie/27735/. 
4 The choices given were strongly disagree, disagree, neutral, agree, 
and strongly agree.
5 Kondrad E and Reid A (2013) Colorado family physicians’ attitudes 
toward medical marijuana, J Am Board Fam Med, 26(1): 52–60. 
6 Crowley D, Collins C, Delargy I, Laird E and Van Hout MC (2017) Irish 
general practitioner attitudes toward decriminalisation and medical 
use of cannabis: results from a national survey, Harm Reduct J, 
14(1): https://www.drugsandalcohol.ie/26675/
In their discussion on the findings, the authors argue that 
while their study suggests that patients are in favour of the 
use of medicinal cannabis and that a majority believe it has 
health benefits, this is contrary to that found in studies of 
physicians. To support this, they cite a study of physicians 
from Colorado, USA that showed ‘the opposite with a lack of 
support for medicinal cannabis and only a minority believing 
it confers a health benefit’.5 
However, they do not refer to the findings of a study of Irish 
GPs’ attitudes to cannabis, which found that 58.6% agreed 
that ‘cannabis should be legalised for medical use’ and 
that 63.5% agreed that ‘cannabis has a role to play in pain 
management’.6 The authors conclude by saying that it is their 
opinion that patients with chronic pain should be included in 
the Government’s access programme for medicinal cannabis.
Attitudes to medicinal cannabis 
continued
Human rights and 
equality of drug 
treatment service 
users 
Our life, our voice, our say is a report published in March 
2018 by the Community Action Network (CAN).1 It highlights 
a range of challenges faced by service users of opioid 
treatment in Ireland, framing them in the context of 
users’ human rights and service providers’ obligations 
under the Irish Human Rights and Equality Commission 
Act 2014 (IHRECA 2014). Since the introduction of the 
Act, public bodies have been required to take proactive 
steps to promote equality, protect human rights, and fight 
discrimination in relation to their functions and powers. 
The report is the main output of a project on the topic. It 
was coordinated by CAN with support from the Irish Human 
Rights and Equality Commission (IHREC). It contains the 
findings of the project as well as a set of recommendations 
from the project’s steering committee.
Methods
The report is heavily grounded in the views and experiences 
of service users. It draws on a number of strands of 
evidence: a service-user survey; a ‘dialogue’ event; an 
analysis of relevant legal frameworks; and analysis of relevant 
health policies and guidelines. The survey of service users 
had two rounds: the first was carried out in 2012 and the 
second in 2017. 
Two dialogue events represented the ‘microcosm of the drug 
services’ and involved consultation between all stakeholders 
in opioid service provision. The first event was supported by 
President Michael D Higgins; the second was attended by 
Catherine Byrne TD, Minister of State for Health Promotion 
and the National Drugs Strategy. 
Key issues
The report is structured around four main sections. Each 
section explores service users’ experiences, the legal 
framework, and any relevant guidelines as they relate to the 
topic under consideration. The four topics are: 
• The practice and frequency of supervised urine sampling
• The meaningful engagement of service users in drug 
treatment service delivery
• Treatment choices and care plans
• Effective complaints mechanism 
Recommendations
The project steering committee made a set of 
recommendations based on the findings. It is beyond the 
scope of this article to list all 28 recommendations but a 
selection is reported below.
Supervised urine sampling
The report is highly critical of the practice of supervised and 
frequent urine sampling. It is recommended that the Health 
Service Executive (HSE) provides training and awareness for 
medical and administrative staff on the following: 
• More evidence-based approaches to providing adequate 
levels of treatment and care to service users, including 
the limitations of urine sampling as a condition for 
service users accessing treatment.
• The diverse experience of people accessing drug 
services, including specific issues arising from urine 
sampling for particular groups. For example, women, 
transgender people, people with disabilities or people 
who may have suffered abuse.
 
Meaningful engagement of service users in drug treatment 
service delivery
Recommendations under this topic include that: 
• The HSE ensures an end to the culture of blame, stigma 
and punishment that is reflected in the experiences of 
the service users documented in the report.
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• The HSE ensures that all service users are informed of 
their right to make a complaint, through an independent 
system of complaints.
Concluding comment
This report provides valuable insights into challenges facing 
service users of opioid treatment services in Ireland and the 
obligations of providers under various elements of legislation 
and guidelines. As mentioned in a previous Drugnet article,2 
under the IHREC Act ‘in preparing strategic plans, public 
sector bodies must assess and identify the human rights 
and equality issues that are relevant to their functions. 
These issues must relate to all of its functions as policy 
maker, employer and service provider’ (p. 4).3 Despite this, 
a human rights and equality assessment was not reported 
to have been carried out as part of the methodology used 
to develop the new national drug and alcohol strategy.4 This 
report highlights the opportunities for services to be more 
proactive in this area. As recommended by the authors, the 
report could be a useful document to disseminate to service 
providers to encourage a more client-centred approach to 
service delivery. 
Lucy Dillon
1 Community Action Network (2018) Our life, our voice, our 
say: applying a public sector equality and human rights duty 
approach to the human rights and equality issues identified by 
service users of opioid treatment services. Dublin: Community 
Action Network. https://www.drugsandalcohol.ie/28876/ 
2 Dillon L (2017) Human rights and the new drugs strategy, Drugnet 
Ireland, 63: 12. https://www.drugsandalcohol.ie/28231/
3 Irish Human Rights and Equality Commission (2016) The public 
sector duty: eliminating discrimination, promoting equality and 
protecting human rights. Dublin: Irish Human Rights and Equality 
Commission. http://www.drugsandalcohol.ie/27649/
4 Department of Health (2017) Reducing harm, supporting 
recovery: a health-led response to drug and alcohol use  
in Ireland 2017–2025. Dublin: Department of Health.  
http://www.drugsandalcohol.ie/27603/
 
• The HSE puts a greater emphasis on building a positive 
relationship and open dialogue between service users 
and service providers and for a deeper and more 
meaningful service-user engagement.
• The HSE designs and promotes dispensing and treatment 
structures that are person-centred and flexible; 
recognises the diversity of service users; and aims to 
facilitate service users to engage in employment, training, 
education and carrying out family and caring duties.
• The HSE recognises the value of consultation and that 
service users are diverse and are not represented by one 
umbrella organisation. 
Treatment choices and care plans
The project steering committee recommends that: 
• The HSE engages with service users to review the 
provision on treatment choice – including Suboxone®, 
Subutex®, methadone maintenance, methadone detox, 
methadone tablets, residential and community detox – 
and ensures it is accessible and usable for service users 
in all drug services.
• The HSE ensures that all drug treatment services provide 
meaningful holistic care plans that are informed by 
service users’ personal goals and clearly documented in 
an accessible manner, and are subject to regular review 
and update.
Effective complaints mechanism 
Recommendations under this topic include that:
• The HSE engages with service users to develop and 
implement a positive action plan to ensure that 
information on a complaints system is available in an 
accessible manner.
Drug treatment service users' 
human rights continued
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18 • Among respondents who were in paid employment, 14% 
reported harm due to co-workers’ drinking. The specific 
harms most often mentioned were reduced productivity 
(7%) and having to cover for co-workers due to their 
drinking (7%). Those more likely to report harm from 
co-workers’ drinking were men and those in the youngest 
age group (18–29 years). 
• Overall, one in six carers (16%) reported that children for 
whom they had parental responsibility experienced harm 
as a result of someone else’s drinking. The most common 
specific harms were a child negatively affected (12%), 
followed by verbal abuse (9%), and a child witnessing 
serious violence in the home (4%). Carers from the 
lowest household weekly income group and those 
separated were most likely to report harm to children 
due to others’ drinking.
• Among respondents who reported being negatively 
affected by the drinking of people they knew, 42.5% 
experienced alcohol-related domestic problems. The 
most common specific harms were family problems, 
feeling threatened at home, shoved or pushed, and 
having less money for the household. Those more likely 
to experience alcohol-related domestic problems were 
women, those under 45 years of age, those with lower 
secondary education, and those who were separated.
Burden on those around the drinker
Three in five (61%) reported having a known heavy drinker in 
their life or someone who drinks a lot sometimes. Of those 
with a known heavy drinker in their lives, 53% reported some 
form of lost time due to caring duties because of the known 
heavy drinker’s drinking in the previous 12 months. The 
most frequently reported caring duties were taxiing (32%), 
caring for the drinker (28%), cleaning-up after the drinker 
(24%), and taking on extra responsibilities caring for children 
or others (17%). One in five (19%) respondents reported 
experiencing harm due to others’ drinking that had a financial 
cost. The harms that resulted in a financial cost included 
ruined clothing or other belongings, property damage, less 
money for household expenses, stolen money, financial 
trouble, and a traffic accident due to others’ drinking. 
Table 1: Costs associated with alcohol’s harms to others
Cost area Cost estimates 
Caring for the drinker €456,513,453
Cost burden of specific harms from 
others' drinking (out-of-pocket expenses)
€129,906,901
Seeking help services – law enforcement 
and health services
€126,724,568
Seeking health services  
(out-of-pocket expenses)
€27,004,933
Workplace costs €122,598,569
Estimated total costs €862,748,424
Overall financial burden of harms from others’ drinking
The total estimated cost of alcohol’s costs to others was 
€862.75 million (see Table 1). Over one-half (53%) of the cost 
was accounted for by the cost of caring for the known heavy 
drinker. The authors state that a conservative approach was 
used in estimating the cost of caring for a known drinker, 
which was confined to two of the caring duties (caring for 
the drinker and caring for children and others). The second 
most significant element of costs (14.8%) was the cost of 
PREVALENCE AND CURRENT SITUATION 
The untold story: 
harms experienced 
in the Irish 
population due to 
others’ drinking
In the last decade there has been a substantial increase 
in research relating to alcohol’s harm to others; and 
international research indicates that a significant proportion 
of the population has experienced harm from other people’s 
drinking. On 16 April 2018, the Health Service Executive (HSE) 
launched the results of the first dedicated Irish survey on 
alcohol’s harm to others.1 The survey was undertaken in 2015 
using CATI (computer assisted telephone interviewing) and 
employed a probability sample. The total completed sample 
was 2,005 and the response rate was 37.2%. The survey 
comprised three main parts:
• Harm from others’ drinking (including strangers, co-
workers and known drinkers); harm to children from 
others’ drinking; and alcohol-related domestic problems 
due to others’ drinking.
• The burden on those around the drinker, for example, 
caring for the drinker; the burden of specific harms from 
drinkers with a cost impact; and having to seek help due 
to the drinking of others.
• The financial burden of harms from others’ drinking, 
including the estimated cost of caring for the drinker; 
having to seek public services due to others’ drinking; 
out-of-pocket expenses; and estimated workplace costs 
related to co-workers’ drinking.
Main findings
Harm from others’ drinking
• In the 12 months prior to the survey, 51% reported 
experiencing harm due to strangers’ drinking. The most 
common specific harms reported were being kept 
awake at night by drunken noise (26%), harassed on the 
street (23%), and feeling unsafe in public places (19%). 
The profile of those more likely to report harm from 
strangers’ drinking were men, those under 60 and those 
with higher education. 
• Two in five (44%) reported experiencing harm from 
known drinkers in their life. The most common of these 
harms were being stressed or anxious (22%), called 
names or insulted (16%), and harassed in private (16%). 
More women than men reported the psychological harm 
items of stress, family problems, feeling threatened at 
home, feeling depressed, and having financial trouble 
due to the drinking of known drinkers, while more men 
reported the tangible harm items of being a passenger 
with a drunk driver and of ruined belongings. 
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the drinker and is also felt by strangers in public spaces. 
The annual estimated cost of harm due to others’ drinking 
in Ireland is just under €863 million. This cost estimate only 
includes tangible costs and not the intangible cost (fear, pain, 
suffering, lost quality of life) of alcohol’s harm to others, which 
are likely to be substantial. It also excludes information from 
health and social agencies, including police data, road crash 
mortality and morbidity, deaths statistics, hospital records, 
child protection agency data, alcohol and drug services 
and helpline data. This report highlights that preventing and 
reducing harm to others is an urgent public health goal.
Deirdre Mongan
1 Hope A, Barry J and Byrne S (2018) The untold story:  
harms experienced in the Irish population due to others’  
drinking. Dublin: Health Service Executive.  
https://www.drugsandalcohol.ie/28839/
out-of-pocket expenses related to specific harms due to 
drinking by others. The cost of seeking help due to drinking 
by others (14.5%) was the third most significant element of 
the total costs. Finally, the cost of drinking by others in the 
workplace accounted for 14% of total costs. However, this 
only represents the cost of additional days that had to be 
worked due to co-workers’ drinking and the cost of days lost 
from work due to others’ drinking. 
Conclusion
The results presented in this survey indicate that the harms 
from others’ drinking is evident across Irish society and is 
experienced by the family, friends and work colleagues of 
Harms due to others’ drinking 
continued
Detecting problem 
alcohol use in Irish 
general practice
A recent report from the World Health Organization (WHO) 
demonstrated that almost one-half of Irish drinkers engage 
in heavy drinking on a regular basis, placing Ireland’s binge 
drinking rates at the second highest of 174 countries studied.1 
In addition, per capita alcohol consumption in Ireland has 
trebled over the past four decades,2 an increase that has been 
associated with an earlier age at commencing drinking, with 
research indicating a rise in alcohol use among students in 
Ireland and increasing levels of high-risk drinking.3 Policymakers 
have attempted to combat this problem, as tailoring effective 
public health policy is crucial in tackling this burgeoning issue. 
Nevertheless, successive legislation has so far been largely 
ineffective in addressing the alcohol crisis in Ireland.
It is recognised that general practitioners (GPs) commonly 
see patients with a range of alcohol-related risks and 
problems. GPs have thus been identified as appropriate 
professionals to screen for those at risk of problem alcohol 
use and to conduct brief interventions to influence patients 
to think more actively about their alcohol consumption. 
Nevertheless, despite the magnitude of the national alcohol 
problem and the detrimental effects on health and society, 
there is a surprising lack of data from general practice in 
Ireland on the documentation of alcohol use and treatment.
Recent research aimed to investigate the prevalence of 
documentation of problem alcohol use in patient records in 
Irish general practice and to describe the documentation of 
its diagnosis and treatment.4 In this study, published in the 
BMC journal Family Practice, GPs affiliated with the Graduate 
Entry Medical School of the University of Limerick were invited 
to participate in the study. Seventy-one per cent of the 
practices participated. One hundred patients were randomly 
selected from each participating practice and the clinical 
records were reviewed for evidence of problem alcohol use. 
Evidence included text in consultation notes; evidence of a 
pharmacological treatment or psychological intervention by 
the GP; evidence of a referral to another primary healthcare 
professional or specialist agencies, and/or diagnostic coding.
Key findings from the study included the following:
• Only 57 patients (1.5%, 95% CI: 1–2%) were identified as 
having problem alcohol use in the previous two years.
• Of the 40 participating practices, 14 (35%) had no 
patients in their sample with documented problem 
alcohol use.
• Patients with problem alcohol use were more likely to 
be male than those without any problem alcohol use 
documented (65% vs 47%, p=0.007).
• 23 patients (0.6%, 95% CI: 0.4–0.9%) were identified as 
having substance use other than alcohol documented in 
the previous two years.
• 29 (51%) of those with documented problem alcohol 
use were referred to other specialist services; 28 (49%) 
received a psychological intervention, mostly counselling 
or a brief intervention.
As this is the first large-scale study of patient records 
in general practice in Ireland looking at documentation 
of screening and treatment of problem alcohol use, the 
study authors highlight the current lack of documentation 
of alcohol problems and the need to reinforce positive 
attitudes among GPs in relation to preventive work.
Seán Millar
1 WHO (2014) Global status report on alcohol and  
health, 2014. Geneva: World Health Organization.  
https://www.drugsandalcohol.ie/21884/ 
2 OECD (2014) Health statistics. Paris: Organisation for Economic 
Co-operation and Development. 
3 Davoren MP, Shiely F, Byrne M and Perry IJ (2015) Hazardous 
alcohol consumption among university students in Ireland:  
a cross-sectional study, BMJ Open, 5(1): e006045.  
https://www.drugsandalcohol.ie/23350/ 
4 O’Regan A, Cullen W, Hickey L, Meagher D and Hannigan A (2018)  
Is problem alcohol use being detected and treated in Irish  
general practice?, BMC Family Practice, 19: 30.  
https://www.drugsandalcohol.ie/28595/ 
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18 In terms of the consequences of online gambling, around 
three-quarters of respondents had to borrow money or sell 
something to get money to gamble (75%) and had experienced 
financial problems in their household as a result of their 
online gambling (74.5%). In addition, 67.3% of respondents 
reported health problems including stress and anxiety as a 
result of gambling; 64.4% felt they might have a problem with 
gambling; and more than one-half (53.4%) went back another 
day to try to win back money they had lost. Although 64.4% 
of respondents felt they have a problem with online gambling, 
at least 80% had never received treatment. Among those 
that received treatment, Gamblers Anonymous was the most 
accessed option (10.3%), followed by counselling (8.8%) and 
medication (1.6%). Finally, around three-quarters (76%) of 
respondents agreed that the potential dangers of gambling 
should be advertised. 
Conclusion
Negative financial and mental health consequences were 
evident for high percentages of respondents and are suggestive 
of problem gambling. However, scale scores were not reported. 
Although many respondents experienced negative effects, 
the majority had never received any treatment. Previous 
research suggests that those who engage in conventional 
(offline) gambling (versus online gambling) are more likely to 
acknowledge the need for treatment.9 This suggests the specific 
targeting of information and support to those gambling in online 
environments. The authors conclude that similar behavioural 
profiles exist among their sample as among samples in studies 
from the UK and beyond. As the sample was self-selecting, it 
may not be representative of the wider population of persons 
who gamble online. Reliance on respondents’ estimations of 
their online gambling experiences may further introduce bias, 
as self-reporting may lack accuracy. It is also worth noting that 
no information is provided on conventional gambling behaviours 
among the sample studied.
Cathy Kelleher
1 Columb D and O’Gara C (2017) A national survey of online  
gambling behaviours, Ir J Psychol Med. [Early online]  
https://www.drugsandalcohol.ie/28197/ 
2 McCormack A, Shorter GW and Griffiths MD (2013) An examination 
of participation in online gambling activities and the relationship 
with problem gambling, J Behav Addict, 2(1): 31–41.
3 Jazaeri SA and Habil MH (2012) Reviewing two types of addiction – 
pathological gambling problems, Indian J Psychol Med, 34(1): 5–11.
4 LaPlante DA, Nelson SE and Gray HM (2014) Breadth and depth 
involvement: understanding internet gambling involvement and its 
relationship to gambling and substance use,, Psychol Addict Behav, 
28(2): 396–403.
5 Scholes-Balog KE and Hemphill SA (2012) Relationships between 
online gambling, mental health, and substance use: a review, 
Cyberpsychol Behav Soc Netw, 15(12): 688–92.
6 Wood RT and Griffiths MD (2015) Understanding positive play: 
an exploration of playing experiences and responsible gambling 
practices, J Gambl Stud, 31(4): 1715–34.
7 Kairouz S, Paradis C and Nadeau L (2012) Are online gamblers more 
at risk than offline gamblers?, Cyberpsychol Behav Soc Netw, 15(3): 
175–80. 
8 Currie SR, Hodgins DC and Casey DM (2013) Validity of the Problem 
Gambling Severity Index interpretive categories, J Gambl Stud, 
29(2): 311–27.
9 Blaszczynski A, Russell A, Gainsbury S and Hing N (2016) Mental 
health and online, land-based and mixed gamblers, J Gambl Stud, 
32(1): 261–75. 
A national survey 
of online gambling 
behaviours
A recent study published in the Irish Journal of Psychological 
Medicine1 aimed to examine attitudes and behaviours of 
persons who engage in online gambling, a topic under-
researched in Ireland to date. Modelled on previous research 
in the UK context,2 the current study sought to explore 
attitudes towards and reasons for online gambling, as well as 
the consequences of online gambling for those who partake. 
The ease and anonymity afforded by online gambling has 
led to growing concern about its addictive qualities and the 
potential for an increase in the incidence and prevalence of 
problem gambling as well as harmful effects. In this study, 
problem gambling is defined as ‘an urge to gamble despite 
harmful negative consequences or a desire to stop’ (p. 1).3 
Some existing research suggests that certain behaviours may 
be indicative of problem gambling; for example, engaging in 
two or more activities online, or in certain activities such as 
live action sports betting and poker.2,4 Other research has 
examined the effects of problem gambling on mental health,5 
and has characterised ‘responsible gambling’ as gambling for 
leisure, and problem gambling as gambling in order to alter 
one’s mood state.6 Differences also exist between those who 
gamble offline and those who gamble online, with the latter 
more likely to report alcohol and cannabis misuse.7
Methodology
The authors analysed data from 208 participants (178 males 
and 30 females), who voluntarily and anonymously completed 
an online survey advertised for seven months on internet sites 
and within general media outlets. The survey contained items 
addressing behavioural aspects of online gambling (e.g. types 
of activities, devices used, and time spent gambling); reasons 
for and attitudes towards online gambling; and mental health 
and financial consequences of online gambling. The survey 
contained the nine items that comprise the Problem Gambling 
Severity Index,8 a scale measuring the severity and impact 
of online gambling in the lives of people who engage in this 
behaviour. While the final sample included respondents from 
across Ireland and Northern Ireland, the majority (42%) were 
from Dublin. The mean age of respondents was 38.9 years (39 
years for males and 38.5 years for females).
Key findings
Horse-race betting (27%) and sports betting (24%) were 
the most common activities for those regularly (most 
days) gambling online, while lottery (26.9%) was the most 
common activity engaged in infrequently (less than once per 
month). The findings suggest that males gamble online more 
regularly than females, and that females are likely to spend 
less time gambling than are males. Among respondents, 
the most common reasons for online gambling were to 
win money (84.6%), enjoyment (76%), access (71.2%) and 
availability (65.4%). The most common emotion experienced 
was excitement (60.6%), followed by happy (35.5%) and 
no difference (31.7%). Around one-quarter of respondents 
reported feeling frustrated (27.4%) and irritable (24.5%) 
while gambling online. 
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• 58 (29%) were positive for hepatitis B (HBV) surface 
antigen, representing a decrease of 11% compared to 2015.
• 40 (20%) were positive for hepatitis C (HCV) antibody,  
a decrease of 27% compared to 2015.
• 21 (11%) had positive treponemal serology (syphilis), an 
increase of 17% compared to 2015.
• 59 (29%) women attended for addiction support 
services, 38 of whom were participating in a prescription 
methadone maintenance programme, an increase of 14% 
compared to 2015. 
It should be noted that these numbers refer to patients 
who booked for care during 2016. Table 1 summarises the 
outcome of patients who actually delivered during 2016. Of 
these patients, 27 were HIV-positive, 66 were HBV-positive, 
and 40 were HCV-positive. A total of 60 deliveries were to 
mothers attending the drug liaison midwife. 
Seán Millar
1 Rotunda Hospital (2017) The Rotunda Hospital: Annual report 
2016. Dublin: Rotunda Hospital. https://www.drugsandalcohol.
ie/28546/
DOVE Clinic, 
Rotunda Hospital 
annual report, 2016
The DOVE Clinic in the Rotunda Hospital, Dublin was 
established to meet the specific needs of pregnant women 
who have, or are at risk of, blood-borne or sexually 
transmitted bacterial or viral infections in pregnancy. 
Exposure may also occur through illicit drug use. Figures 
from the clinic for 2016 were published in the hospital’s 
annual report in 2017.1
The number of women admitted to the DOVE Clinic for 
antenatal care for the years 2006–2016 by diagnosis is shown 
in Figure 1. During 2016, some 201 women booked into the 
DOVE Clinic for antenatal care. Of these:
• 27 (13%) were positive for HIV, an increase of 13% 
compared to 2015.
Table 1: Deliveries to mothers attending the DOVE Clinic who were positive for HIV, HBV, HCV or syphilis  
or who were attending the drug liaison midwife, 2016
Mother’s status HIV HBV HCV Syphilis DLM
 (+ve) (+ve) (+ve) (+ve)
Total mothers delivered 27 66 40 16 60
Total mothers delivered <500g (incl. miscarriage) 0 0 2 1 1
Total mothers delivered >500g 27 66 38 15 59
Live infants 27 66 40/41* 16/18** 59/60**
Miscarriage 0 0 2** 0 0
Stillbirth 0 0 1 1 1
Infants <37 weeks’ gestation 3 4 6 3 10
Infants >37 weeks’ gestation 24 62 34 13 50
Caesarean section 12 14 14 6 21
HIV, HBV, HCV or syphilis-positive infants 1 0 1 0 –
Maternal mean age 31 30 33 33.5 –
Source: The Rotunda Hospital: Annual report, 2016
*Including three sets of twins. **Including one set of twins. DLM = Drug liaison midwife.
Figure 1: DOVE Clinic bookings by year, 2006–2016
Source: The Rotunda Hospital: Annual report, 2016
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18 overdose only (89.5%), with self-cutting identified as the most 
common combined method, involved in 6.5% of IDOs. Alcohol 
was present in 40.6% of IDOs and was more common in male 
presentations (44.7% vs 37.8%, p<0.01). The median number 
of total tablets taken per IDO case was 23 for males and 20 
for females, with over one-third of presentations involving the 
ingestion of between 20 and 49 tablets.
The drugs that were most frequently used in IDO are shown 
in Figure 1. The most frequently used drug was paracetamol, 
which was involved in 27.8% of IDOs. Anti-inflammatory 
drugs (ibuprofen and diclofenac) and antidepressant drugs 
(escitalopram and venlafaxine) were also frequently taken in 
IDO (6.6%, 2.4%, 5.1% and 3.4%, respectively). Illegal drugs 
were involved in 6.0% of IDOs.
Other key findings from the study included the following: 
• Significant gender differences were found in relation to 
drugs involved in IDO. Musculoskeletal system drugs were 
significantly more common in female IDOs compared 
with male IDOs (14.0% vs 9.2%, p<0.01). Similarly, IDOs 
involving analgesics and antidepressants were significantly 
more common in female presentations (36.4% vs 
26.7%, p<0.01 and 23.9% vs 19.1%, p<0.01). In particular, 
paracetamol was involved significantly more often in 
female IDOs (32.0% vs 21.7%, p<0.01). 
• Illegal drugs were three times more common in male 
compared with female presentations (10.1% vs 3.1%, 
p<0.01).
• Alcohol involvement in IDO was significantly higher in 
male compared with female presentations (44.7% vs 
37.8%, p<0.01). 
• Alcohol was most frequently consumed in presentations 
involving illegal drugs (47.8%) followed by anxiolytics 
(49.3%, p<0.01).
Frequently used  
drug types and 
intentional drug 
overdoses in Ireland
Intentional drug overdose (IDO) is the most common 
form of hospital-treated self-harm, involved in 65–85% 
of presentations in Ireland, as reported by National Self-
Harm Registry Ireland.1 However, no national study has 
systematically classified the range of drugs involved using 
a validated system in Ireland. The Anatomical Therapeutic 
Chemical (ATC) system is a World Health Organization-
recommended classification system designed to measure 
drug utilisation at an internationally comparable level.2 
Recently conducted research aimed to examine drugs taken 
in IDO according to the ATC classification.3
In this study, published in the European Journal of Public 
Health, presentations of IDO in the Republic of Ireland for the 
period 1 January 2012 to 31 December 2014 were examined 
and information on demographic and overdose characteristics 
obtained. Drugs were classified according to their use at the 
time of ATC system application (December 2016). Illegal drugs 
were identified using the Misuse of Drugs Acts.4
Results
During the study period, there were 18,329 self-harm 
presentations involving IDO, representing 67.6% of all self-harm 
presentations. The majority (58.7%) of presentations were 
made by females. The majority of IDO presentations involved 
Figure 1: Drugs frequently involved in IDO in Ireland, total and by gender, 2012–2014
Source: Daly et al., 20183
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Europol
The main agency involved in law enforcement in the EU 
is Europol. Its key role is to support EU member states 
combat serious international crime and terrorism (p. 7). A 
designated team of experienced specialists and analysts 
based in Europol’s European Serious and Organised Crime 
Centre (ESOCC) are available to liaise with and support 
member states in the fight against illegal drugs. The most 
commonly shared information between Europol and EU law 
enforcement agencies is on drug-related investigations and 
operations. 
EU policy cycle
The EU policy cycle, EMPACT (European Multidisciplinary 
Platform against Criminal Threats), provides the framework 
that brings member states, law enforcement agencies, 
Europol and other multidisciplinary agencies together to 
combat serious and organised crime. The priorities identified 
are centred on analyses carried out by the EU Serious and 
Organised Threat Assessment (EU SOCTA) and the Justice and 
Home Affairs Council of the EU. The production, trafficking 
and distribution of illegal drugs have been identified as one 
of the key areas to be targeted between 2018 and 2021.2
Emerging threats
Darknet
A platform increasingly utilised by OCGs in the sale of  
illegal drugs is the darknet market. There are several  
reasons for this: 
•  It is hard to control by police but easily accessed. 
• It offers anonymity.
• It makes a secure environment available from which to 
sell a range of illegal drugs and other illegal products.  
Darknet markets have resulted in a substantial increase in 
EU drug trafficking via postal and parcel services. In 2017, 
following an international collaboration between EU and 
United States law enforcement agencies, two platforms, 
AlphaBay and Hansa, were taken down. 
How illegal drugs 
sustain organised 
crime in the EU
A report published in December 2017 by Europol provided an 
overview of how illegal drugs sustain organised crime within 
the European Union (EU).1
Introduction
European drug markets
Drug markets continue to be the most important illegal 
market in the EU. Over 33% of organised criminal groups 
(OCGs) have participated in the production, trafficking and 
supply of illicit drugs, resulting in extensive profits that have 
enabled a range of illegal activities to be funded. OCGs that 
participate in the drugs trade are mainly ‘poly-criminal’, 
that is, they mainly traffic more than one product. Moreover, 
many OCGs participate in other illegal activities, for example, 
counterfeit goods, trafficking human beings and migrant 
smuggling, at the same time. In addition, drugs are utilised as 
a form of payment among OCGs; for example, cannabis may 
be exchanged for cocaine. 
The drug market has become more and more competitive, 
which can and has resulted in violent rivalries between OCGs 
as they mark their territories. Advanced technology, such 
as climate control systems, CO2 and ozone generators, and 
chemical equipment, have further enabled OCGs to increase 
production, while advanced communication, such as 
encryption, have made disruption by law enforcement more 
challenging. Advancements in drone technology are likely to 
create further problems, enabling OCGs to avoid checks at 
borders, airport and ports.
Conclusions
The results from this research suggest that people who 
engage in IDO frequently take prescription only or sales-
restricted drugs, and that IDOs often involve alcohol and/
or polydrug use. The authors concluded that the findings 
highlight the importance of addressing drug and alcohol 
misuse, potential inappropriate prescribing, and the 
enforcement of legislation restricting specific drug sales. 
Seán Millar
1 Perry IJ, Corcoran P, Fitzgerald AP, Keeley HS, Reulbach U and 
Arensman E (2012) The incidence and repetition of hospital-
treated deliberate self harm: findings from the world’s first national 
registry. PLOS One, 7(2): e31663. https://www.drugsandalcohol.
ie/17030/ 
2 World Health Organization (2018) Guidelines for ATC 
classification and DDD assignment. Oslo: WHO Collaborating 
Centre for Drug Statistics Methodology. Available online at:  
https://www.whocc.no/filearchive/publications/guidelines.pdf 
3 Daly C, Griffin E, Ashcroft DM, Webb RT, Perry IJ and Arensman 
E (2018) Frequently used drug types and alcohol involvement in 
intentional drug overdoses in Ireland: a national registry study.  
Eur J Public Health 28(4): 681–86. https://www.drugsandalcohol.
ie/28709/ 
4 Misuse of Drugs Act 1984. Irish Statute Book.  
Available online at: http://www.irishstatutebook.ie/eli/ 
1984/act/18/enacted/en/print.html
Intentional drug overdoses  
continued
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18 Terrorism
In the previous 10 years, terrorism and how it is carried 
out has changed. The EU has been subjected to numerous 
attacks and plots. It is believed that terrorist activities have 
been financed within and outside the EU from revenue 
obtained through smuggling and supplying illegal drugs. This 
is not something new; the routes utilised to smuggle drugs 
have long been linked to terrorist-related activities. 
Money laundering
Criminal activity centred on illegal drugs results in large-
scale profits for OCGs. Money laundering enables OCGs to 
move the proceeds of crime into economies that are lawful. 
This can be done in two ways: OCGs can launder funds 
themselves into businesses and real estate or they can avail 
of money-laundering syndicates who charge a fee. Money-
laundering activities are particularly challenging for EU law 
enforcement, who have been shown to be unsuccessful 
in detecting and taking control of illegal funds generated 
by OCGs. New technological developments, for example, 
cryptocurrencies and anonymous payment methods, further 
amplify these issues.  
Ciara H Guiney
1 European Union Agency for Law Enforcement Cooperation 
(Europol) (2017) How illegal drugs sustain organised crime in the 
EU. The Hague: Europol. https://www.drugsandalcohol.ie/28319/
2 European Union (2017) The EU fight against organised crime. 
Available online at: http://www.consilium.europa.eu/en/policies/
eu-fight-against-organised-crime-2018-2021/ 
3 European Monitoring Centre for Drugs and Drug Addiction 
(2018) European drug report 2018: trends and developments. 
Luxembourg: Publications Office of the European Union.  
https://www.drugsandalcohol.ie/29135/
New psychoactive substances
New psychoactive substances (NPS), which cover a diverse 
range of substances that mimic the effects of traditional 
drugs like cannabis and cocaine (e.g. synthetic cannabinoids, 
stimulants, opioids and benzodiazepines), continue to 
emerge on EU markets. The consumption of NPS places 
considerable risk on the health and wellbeing of users and 
has been associated with death. Currently, 670 NPS are 
being monitored by the European Monitoring Centre for 
Drugs and Drugs Addiction (EMCDDA).3 
Fentanyl and its analogues
Fentanyls, which are viewed as ‘highly potent opioid narcotic 
drugs’ (p. 10), are utilised as medicines (anaesthesia and pain 
relief) and for controlling large animals. They are used as 
substitutes for heroin and other illegal opioids. New fentanyls 
are not regulated under the International Drug Control 
Conventions put forward by the United Nations. As a  
result, they are produced and sold openly in several  
EU member states.
Situational picture
The trafficking and distribution of illegal drugs, such as 
cannabis, cocaine, heroin, synthetic drugs and NPS, have 
proven to be lucrative for OCGs and resulted in extensive 
profits for all involved. 
Links to the trade in illegal drugs
Two main activities are associated with the illegal drugs 
trade: terrorism and money laundering. 
Illegal drugs and organised crime 
continued
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RESPONSES 
A decade of the 
Strengthening 
Families Programme 
in Ireland
The Strengthening Families Programme (SFP) was first 
introduced in Ireland in 2007. To mark the 10th year of 
the programme here, the National Strengthening Families 
Programme Council of Ireland (NSFPCI) collaborated with 
its members to collate data collected on the programme 
over the decade. It presented the findings at the 8th 
Conference of the European Society for Prevention Research 
(EUSPR), ‘Quality in Prevention’, held in September 2017.1 
This has been followed up with the report, Family effects: 
Strengthening Families Programme 10 year outcomes in 
Ireland, which was published in March 2018.2
Strengthening Families Programme
The Strengthening Families Programme was developed in 
the USA in 1982 and is now being delivered in an estimated 
36 countries. It is a parenting and family skills training 
programme for high-risk and general population families. 
Internationally, there are a number of variants of the 
programme. In Ireland, the focus has been on the 14-week 
model that works with families with children aged 12–16 
years, although some sites also deliver the programme for 
families with children aged 6–11 years. It is designed to build 
parents’ and children’s healthy skills and create positive 
relationships within families.3
Outcomes in Ireland 
Family effects provides an overview of the programme 
and a summary of key – largely positive – findings from 
evaluations of its delivery in Ireland over the past 10 years.4 
It also presents the findings of an effort to capture collective 
outcomes at a national level. Analysis was carried out on 
data collected from 573 of the families who completed the 
programme in Ireland. Data were only collected from parents 
using a questionnaire that aimed to capture how their and 
their family’s behaviour had changed from before to after 
completing the programme (a retrospective pre- and post-
test design questionnaire). This standardised instrument 
was developed by the programme developers in the USA. 
It was designed to assess ‘child and parent mental health, 
substance abuse, risk and resiliencies, family management 
and cohesiveness, and parent and child social skills and 
attitudes’ (p. 20).
While there are limitations to the methods used to look at 
these outcomes, the overall findings were positive:
• The authors found a positive effect on parenting 
outcomes across parental involvement, parental 
supervision, parenting efficacy, positive parenting, and 
SFP parenting skills. They only found a small effect in 
relation to parent drug or alcohol use but explain this 
as either due to parents having low levels of use at the 
start of the programme or that it would be too soon to 
measure any such change at the end of the programme.
• Positive effects were also found for children or young 
people for decreased overt/covert aggression and 
depression, and increases in concentration and positive 
social behaviour.
• At a family level, positive outcomes were found for 
conflict, communication, strengths and resilience.
 
The report concludes with a set of recommendations, 
including: 
• To explore the cost-effectiveness of SFP as a family-
based prevention programme.
• To work with academic institutions to improve the 
collection of national data on the programme, including 
that on outcomes.
• To explore ways in which to capture the longer-term 
effects of the programme, with a particular focus on 
teens who have participated in the programme and are 
now parents themselves. 
Lucy Dillon
1 Dillon L (2018) EUSPR conference: quality in prevention, Drugnet 
Ireland, 64: 22–23. https://www.drugsandalcohol.ie/28573/
2 National Strengthening Families Programme Council of  
Ireland (2018) Family effects: Strengthening Families  
Programme 10 year outcomes in Ireland. Dublin: NSFPCI.  
https://www.drugsandalcohol.ie/28737/
3 For further information on the programme, visit  
https://www.strengtheningfamiliesprogram.org/ 
4 One of these evaluations was covered in an earlier Drugnet 
Ireland article. See Keane M (2012) Evaluating the Strengthening 
Families Programme, Drugnet Ireland, 41: 18–19.  
https://www.drugsandalcohol.ie/17281/ 
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18 Screening, treatment and support services
The alcohol strategy aspires to increase the availability 
of alcohol screening and promote and advocate the 
development of treatment services to meet the needs 
of people affected by alcohol misuse. Specifically, the 
strategy will encourage the use of appropriate screening 
and brief advice tools across a range of services; assess and 
strengthen referral systems for existing alcohol treatment 
services in Sligo city; and advocate for additional services 
where gaps in service provision have been identified. In 
addition, the strategy will aim to facilitate the development 
of family supports for those affected by alcohol and support 
the development of a range of services for young people 
affected by alcohol.
Research, monitoring and evaluation
A survey will be conducted to assess behaviours, attitudes 
and awareness in relation to alcohol use in Sligo city. During 
the five-year rollout, a system will be developed to track 
the progress of the strategy. This will include assessing the 
impact at appropriate stages and the level of public support. 
The NWRDATF is keen to engage the public in the discussion 
and debate on both the issues and the possible solutions to 
alcohol-related harm. As Seán O’Connor, coordinator of the 
NWRDATF, explained:
There are strategies which can be put in place that are 
shown to reduce the amount of alcohol-related harm 
without interfering with anyone’s enjoyment of a night out. 
We are hoping to enlist enough support from local people 
and local agencies to implement an appropriate strategy 
for Sligo city.
Seán Millar
1 Northwest Regional Drug and Alcohol Task Force (2018) Sligo city 
alcohol strategy: prevent and reduce alcohol related harm 
2018–2023. Sligo: Northwest Regional Drug and Alcohol Task 
Force. https://www.drugsandalcohol.ie/28725/
Preventing and 
reducing alcohol-
related harm: the 
Sligo city alcohol 
strategy
The Sligo Healthy Ireland Project, in conjunction with the 
Northwest Regional Drug and Alcohol Task Force (NWRDATF), 
has developed an alcohol-related harm reduction strategy 
for Sligo city.1 This five-year strategy will focus on four key 
areas: prevention, supply (including access and availability), 
screening (including treatment and support services), and 
research (including monitoring and evaluation). The overall 
goals are to address alcohol-related harm; ensure factors 
influencing alcohol supply are regulated and controlled; 
advocate for a range of alcohol treatment and support 
services; and use evidence and research to inform decisions 
in preventing and reducing alcohol-related harm in Sligo city.
Prevention
Specific goals with regard to prevention include raising 
public awareness of the burden of alcohol-related harm 
and of the benefits of effective action to prevent alcohol-
related harm. To this end, the strategy will develop and 
implement a communication plan in relation to the harm 
caused by alcohol. The plan will focus on communicating the 
link between alcohol and health issues, family relationship 
issues, and social harms such as crime, violence, and public 
disorder. Effective measures to prevent and reduce alcohol-
related harm will also be communicated.
Supply, access and availability
The strategy will aim to reduce the availability of alcohol 
in Sligo city, reduce the marketing of alcohol in public 
places, and promote responsible drinking practices. This 
will include a review of the density of alcohol outlets in Sligo 
city, the possibility of strengthening zoning regulations to 
reduce the availability of alcohol in the town, and limiting 
the availability of alcohol at civic, sporting and public 
events. In particular, the strategy will advocate for statutory 
regulations at a national level in relation to alcohol marketing 
to protect children and assist licensed traders to be aware of 
regulations on the sale of alcohol and underage drinking.
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Environmental 
prevention
The field of substance misuse prevention continues to evolve. 
There is increasing interest in environmental prevention and the 
role it can play in this field, although to date it has remained ill-
defined and tends to be poorly understood. In February 2018, 
the European Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA) set out to address this deficit and published their 
first significant report on the topic: Environmental substance 
use prevention interventions in Europe.1 The report is made up 
of two sections: the first provides an operational definition 
of environmental preventions (see Box 1 on the right) and a 
short overview of how it has evolved; the second presents 
the findings of a survey of prevention experts that explores 
the current availability in Europe of environmental prevention 
measures for substance use.
What is environmental prevention?
While there has been growing recognition of the importance 
of environmental factors in the context of the wider 
determinants of health, the authors identify the prevention 
field as having been ‘slow to adapt to this broader focus’ 
(p. 8). The report outlines the established prevention 
traditions and explains what environmental prevention can 
add to this field. Traditionally, substance use prevention has 
been based on two broad approaches. First, interventions 
provide warnings about the risks and consequences of 
substance use and offer information on safer ways to use 
substances. Second, they develop young people’s social skills 
and competencies to avoid substance use. Both of these 
approaches focus on the individual as the main driver of 
change. In contrast, environmental prevention interventions 
aim to limit the individual’s exposure to unhealthy or risky 
behaviour opportunities, or to promote the availability of 
healthy options. The focus therefore is on changing the 
environment so that it supports the prevention of drug use. 
Environmental prevention interventions in Ireland are 
focused around increasingly restrictive alcohol and tobacco 
controls; for example, the standardised packaging provisions 
of the Public Health (Standardised Packaging of Tobacco) Act 
2015, which came into force in September 2017. Illustrations 
of typical interventions in Europe are outlined in Box 1.
Environmental prevention in Europe
The authors surveyed prevention experts across Europe. They 
were interested in assessing what environmental prevention 
interventions exist for illicit drug, alcohol and tobacco use, and 
the extent to which they were being implemented. Overall, 
regulatory and economic measures (see Box 1 for definitions) 
were more prevalent than physical environment measures. For 
example, 83% reported national level regulatory measures for 
illicit drugs, 54% for alcohol, and 58% for tobacco. Physical 
measures were not reported for illicit drugs alone, and only 
2% reported them for alcohol; however, they were reported 
by 47% for tobacco. When looking at the extent to which any 
measures were enforced, regulatory and economic measures 
were perceived to have been strongly enforced in only 
limited cases, especially in relation to illicit drugs and alcohol. 
Enforcement was strong for measures related to tobacco. 
While these findings may be affected by some of the study’s 
limitations, which are explicitly acknowledged by the authors, 
they provide valuable insights into this growing field. 
Concluding comment
In a context where there is little evidence of the 
effectiveness of traditional prevention approaches to bring 
about behavioural change in substance use, alternative or 
complementary approaches should be welcomed. This report 
suggests that environmental prevention measures offer a 
complementary approach to the prevention field. This report 
provides ‘a useful starting point’ (p. 6) for creating a greater 
understanding of these measures and a way to assess them.
Lucy Dillon
1 Oncioiu SI, Burkhart G, Calafat A, Duch M, Perman-Howe P  
and Foxcroft DR (2018) Environmental substance use prevention 
interventions in Europe. Technical Report. Lisbon:  
European Monitoring Centre for Drugs and Drug Addiction. 
https://www.drugsandalcohol.ie/28613/ 
Box 1: Environmental prevention:  
EMCDDA’s definition and scope 
The purpose of environmental prevention policies and 
interventions is to limit the availability of unhealthy or 
risky behaviour opportunities (or promote the availability 
of healthy ones). 
Environmental prevention operates by changing the 
physical, economic, or regulatory contexts for behaviour. 
It involves low individual ‘agency’; i.e. individual personal 
resources such as conscious decision making, motivation 
and intent do not need to be used to benefit from 
the specific intervention. Therefore, environmental 
prevention typically works without using persuasive 
messaging, although information can sometimes be 
provided alongside an environmental intervention.
In our definition and scope of environmental prevention 
we have grouped our examples according to the aspect 
of the environment they primarily modify: regulatory, 
economic or physical. These are meant to help organise 
the examples of environmental prevention that we 
provide, but we accept that there may be some overlaps 
between the areas. Nevertheless, we find it a useful way 
to cluster our examples. 
The first type is regulatory environmental prevention 
interventions/measures. These are interventions that 
directly control what is allowable or accessible using 
legislation, regulations, restrictions, policing, institutional 
rules, bans and exclusions. 
The second type is economic environmental prevention 
interventions/measures. These measures influence the 
costs of the healthy/unhealthy options through taxes, 
pricing policies and subsidies. 
The third type is physical environmental interventions/
measures. These are interventions that alter properties or 
placement of objects, stimuli or any built element within 
micro-environments (i.e. offices, bars, etc.) or macro-
environments (i.e. cityscape, landscape, etc.) to foster 
certain health-related behaviour changes.
Source: Environmental substance use prevention interventions in 
Europe, p. 48
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18 recreational and extracurricular youth workers, and other 
interested community members. The third element is 
described as ‘integrative reflection’ (p. 19), whereby the 
impact of the interventions is measured through regular 
data collection, interventions amended in response to the 
findings, and any new issues identified. 
In the Icelandic context, following the mapping of the 
risk and protective factors, a broad range of prevention 
interventions was introduced. These involved significant 
public expenditure and included activities such as 
the extensive development of structured high-quality 
recreational activities for young people and support for 
families to spend more time together. Young people’s 
substance use was monitored on an ongoing basis with a 
focus on measuring outcomes and identifying changing 
needs to inform the ongoing development of effective 
interventions. A dramatic decrease in substance use  
among Icelandic adolescents since 1997 has been attributed 
to this model.2
The Western region
In association with local partners, WRDATF has committed 
to supporting the introduction of Planet Youth to parts of 
the region. As a first step, data will be collected using the 
standardised Planet Youth tool with students in a selection 
of schools. These data will then be analysed by the team at 
the ICSRA and reported back to stakeholders in the WRDATF. 
They will use this information to develop a programme of 
prevention activities tailored to local needs. 
Lucy Dillon
1 The presentations and other materials from the day are available 
online at: http://www.wrdatf.ie/planet-youth.php 
2 Sigfúsdóttir ID, Thorlindsson T, Kristjánsson AL, Roe KM and 
Allegrante JP (2009) Substance use prevention for adolescents: 
the Icelandic Model. Health Promotion International, 24(1): 
16–25. http://www.drugsandalcohol.ie/28656/
Planet Youth
On 20 February 2018, the Western Region Drug and Alcohol 
Task Force (WRDATF) facilitated an event introducing the 
Planet Youth drug prevention programme to key stakeholders 
in the region. Presentations were made by Michéal Durcan 
and Emmet Major of the WRDATF, as well as Jón Sigfússon, 
director of Planet Youth at the Icelandic Centre for Social 
Research and Analysis (ICSRA).1 
Planet Youth: the model
Planet Youth is an evidence-based approach to preventing 
children and adolescents from initiating drug use. The model 
originated in Iceland and has been rolled out in communities 
in 18 countries to date. In the 1990s, a group of Icelandic 
social scientists, policymakers and practitioners began 
collaborating in an effort to address the increasing levels  
of drug and alcohol use among Icelandic young people.  
The prevention model that emerged ‘reflexively and 
continuously links national-level data collection with local-
level reflection and action to increase social capital’ (p. 
19).2 The model is predicated on three pillars of success: 
evidence-based practice; using a community-based 
approach; and creating and maintaining a dialogue among 
research, policy, and practice. 
Based on the presentations at the conference, there are 
three broad elements to the model. First is the collection 
of data from young people through a school-based 
questionnaire. This explores background factors, substance 
use, social circumstances, and potential risk factors 
associated with substance use. These data are then analysed 
to identify the scope of the problem and map out the risk 
and protective factors experienced by the young people in 
that area. The second element is where local stakeholders 
use the findings to plan and deliver a set of prevention 
responses – stakeholders include researchers, policymakers, 
practitioners, parents, school personnel, sports facilitators, 
Drug-related 
cybercrime
In April 2018, An Garda Síochána (AGS) hosted the fifth 
annual meeting of the Council of Europe’s Pompidou Expert 
Working Group on Drug-Related Cybercrime in Dublin Castle. 
The Pompidou Group is the only European multidisciplinary 
intergovernmental body that provides a drug policy 
cooperation platform on drug-related cybercrime issues. 
The meeting brought together a multidisciplinary network  
of specialists and agencies that are directly involved in  
the fight against drug-related crime in Ireland, including  
AGS, the Criminal Assets Bureau and the Health Products 
Regulatory Authority (HPRA), and also in Europe, including 
the European Monitoring Centre for Drugs and Drugs 
Addiction (EMCDDA) and Europol. A number of the topics 
covered are outlined below.
State of play 
Internet, darknet and cryptocurrencies
This session covered drug-related cryptomarkets and the 
manner in which they are monitored. In 2017, two leading 
online marketplaces were taken down: AlphaBay, which  
was targeted as part of Operation Bayonet, and Hansa,  
which was taken over and decrypted by Dutch law 
enforcement agencies. 
Non-English language darknet markets
The author of an EMCDDA study on the darknet explained 
that two-thirds of transactions on the darknet were drug 
related.1 There are several global English markets, and some 
non-English markets that are restricted geographically. The 
role played by national customs agencies and the influence 
of traditional markets and traditional physical drug markets 
on these newer online markets were examined. 
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Cybercrime teams
Presenters provided an overview of policies and activities 
that should be considered when setting up a cybercrime 
team. For example, the Organization for Security and  
Co-operation in Europe (OSCE) has an anti-drug mandate 
aimed at addressing threats to security and stability 
because of drug-related activities. The importance of 
OSCE-supported training was emphasised, as it provided law 
enforcement officers that do not have an IT specialism with 
an opportunity to learn about criminality on the internet, 
dark web, dark markets, Tor browser and virtual currencies. 
Officers also learn online investigative skills and encryption 
and anonymity techniques. An example of a unit that drew 
on simple methods and open source tools that are freely 
available was provided. 
Medical counterfeits and internet
The HPRA, who are responsible for regulating medicines, 
medical devices and other health products in Ireland, 
highlighted the work of Operation Pangea, which is an 
international operation that aims to find, disrupt and take 
down illegal suppliers of medicines and medical devices 
online. A multiagency international approach was highlighted 
as the most effective use of available resources. Moreover, 
this approach demonstrated to offenders that agencies will 
work together to end illegal activities. An overview was also 
provided of existing investigative practices used by the HPRA 
to find individuals dealing medicines online, actions that were 
taken, and issues encountered.
Conclusion
The meeting of the Pompidou Expert Working Group on 
Drug-Related Cybercrime at Dublin Castle provided a 
platform for interesting, extensive, and in-depth discussion 
of current policies and practices, and the lessons learned 
from existing and past operations. The main points that 
emerged consistently during the two-day meeting were 
in order to succeed in the battle against drug-related 
cybercrime, it was essential that there was greater 
collaboration and sharing of information among those 
working in this area at a national, European and global 
level. Secondly, due to the continued advancements and 
evolving nature of the internet and darknet and how it is 
used, ongoing professional development was viewed as vital 
to ensure that law enforcement officers had the necessary 
skillset to enable them to continue to tackle drug-related 
cybercrime.  
Ciara H Guiney 
1 European Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA) and Europol (2017) Drugs and the darknet: 
perspectives for enforcement, research and policy. 
Luxembourg: Publications Office of the European Union.  
https://www.drugsandalcohol.ie/28246
2 Tzanetakis M (2018) Comparing cryptomarkets for drugs.  
A characterisation of sellers and buyers over time. International 
Journal of Drug Policy, 56: 176–186.
 
Tackling darknet criminality
Online trade was viewed as a major threat in Europol’s 
Serious and Organised Crime Threat Assessment (SOCTA) and 
Internet Organised Crime Threat Assessment (IOCTA) 2017. 
Despite this, significant knowledge gaps were identified. 
Potential responses included monitoring, seizures and 
taking down markets using specialised darknet investigation 
teams and cyberpatrol actions. It was anticipated that more 
darknet markets will emerge and that they may replace or 
otherwise significantly impact traditional drug markets. 
Undercover and trust
Money laundering using bitcoin
One presentation described a money-laundering 
investigation that used bitcoin transactions. The benefits and 
concerns of using undercover agents were highlighted. The 
presenter emphasised the importance of using undercover 
agents, advanced technology and classical investigative 
techniques in tandem. Using this approach ensured that the 
process and all individuals involved could be identified.
Comparing drug cryptomarkets
This session included a presentation on a study that 
systematically measured structures and trends on the 
darknet marketplace AlphaBay.1 Data were gathered between 
September 2015 and August 2016. The results indicated 
that 2,188 vendors offered 11,925 drug items that resulted 
in USD 94 million sales in the drugs section. Cocaine-, 
cannabis-, heroin-, and ecstasy-type products accounted 
for approximately 64% of the sales. The main countries of 
origin were the United States, United Kingdom, Australia, the 
Netherlands and Germany. Only 5% of those selling drugs 
earned greater than $200,000, accounting for 53% of total 
revenue reported; and 58% of those selling drugs earned 
below $10,000, which accounted for 3.5% of the total 
revenue. The author concluded that further research was 
necessary to examine the interaction between traditional 
and darknet drug markets.1
Cryptocurrencies
Presentations highlighted the main problems that arose 
when attempting to seize cryptocurrencies. The importance 
of understanding the purpose of a bitcoin transaction in 
the blockchain system was emphasised. Law enforcement 
agencies need to understand the use of concurring 
currencies as part of a blockchain system, how to recognise 
and seize cryptocurrencies, and how to access support from 
technical experts. 
Cybercrime conference 
continued
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18 Table 1: Change in the number of drug squad units by  
country between 2012 and 2015
Country 2012 2015
Austria 10 10
Belgiuma 41b 28
Bulgaria 32 10
Croatiaa — 20c
Cyprus 1 1
Czech Republic 3 2
Denmark 1 13
Estonia 6 5d
Finland 26 0
France 99 209
Germany 250 250
Greecea — 4c
Hungary 2 1
Ireland 29 57
Italy 41 242
Latvia 3 3
Lithuania 12 12
Luxembourg 8 8
Malta 1 1
Netherlands 5 5
Norway 28 0
Portugal 53 70
Poland 301 149
Romania 44 44
Slovakia 2 1d
Slovenia 13 5
Spain 118 3
Swedena — 0c
Turkey 4 4
United Kingdom 54 0
Total 1187 1133c
Source: EMCDDA, 2017, p. 32
a Countries that did not take part in the 2012 study. 
b Figure retroactively provided in the 2015 update. 
c  Countries provided figures for 2015 only; therefore, the number  
of drug squads was not taken into account in the comparison. 
d  Minimum number that could be extracted from the answer provided;  
the real number is likely to be higher.
Drug squads: units 
specialised in drug 
law enforcement  
in Europe
Drug law enforcement via specialised drug units was 
identified by the European Monitoring Centre for Drugs and 
Drugs Addiction (EMCDDA) as an important route to reducing 
drug supply in Europe.1 In 2014, the EMCDDA conducted 
a follow-up study of their earlier paper with the aim of 
monitoring changes in the quantity of specialised drug 
squads and how they are staffed.2 
Methodology
The data for this study were collected between 2012 and  
2015. National reference persons from 28 EU member  
states, Norway and Turkey were invited to complete a  
short questionnaire, which contained items from the original 
study and options to provide further information. Only  
12 participants from the original study completed the 
updated question; the remaining 18 were completed by  
new reference persons.
Results
Drug squads in Europe in 2012 and 2015
The reported drug squad units (DSUs) were located 
within different organisational structures, such as police 
forces, customs, and other law enforcement agencies. In 
consequence, there were differences between functionality, 
administrative and territorial levels. Overall, as shown in 
Table 1, the total number of DSUs decreased across Europe 
between 2012 and 2015. However, in Ireland, the number of 
DSUs nearly doubled, increasing from 29 (2012) to 57 (2015).
Staff numbers within drug squads in Europe 
Overall, there was a 5% increase in the number of staff 
employed in DSUs between 2012 (19,490) and 2015 (20,515) 
across Europe. A further breakdown at a national level 
indicated that some countries showed an increase, for 
example, the Netherlands and Turkey. Other countries 
showed a decrease, for example, Austria and Hungary. 
Three countries, Germany, Latvia and Romania, reported no 
changes to staff levels between 2012 and 2015. In relation to 
Ireland, an increase in staffing levels was shown. Although the 
total number of employees assigned to DSUs increased by 
approximately 3%, the total number of officers assigned to 
DSUs was more than double that amount (7.45%).
Drug law enforcement in countries without drug squads
Several countries indicated that specialised drug law 
enforcement units did not exist in their countries (Finland, 
Sweden, United Kingdom and Norway). The reason put 
forward for this was organisation restructuring that resulted 
in drug units being reintegrated into serious organised  
crime units.
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Conclusion
In the main, the European drug law enforcement situation in 
2015 is similar to that found in 2012. Drug law enforcement 
activities were mainly overseen by the justice department in 
each jurisdiction. Although the number of drug squads and 
law enforcement officers decreased since 2012, the overall 
level of staff employed in this area increased. Countries that 
were more sparsely populated, such as Ireland, reported 
higher proportions of drug law enforcement employees than 
those that were more densely populated. 
The EMCDDA has acknowledged that the update was 
limited and has recommended that drug law enforcement 
processes utilised in European member states should be 
standardised in order to allow comparisons between the 
varied organisations and existing mandates. This would build 
on the current knowledge and understanding of work already 
done in this area. 
Ciara H Guiney
1 European Monitoring Centre for Drugs and Drug Addiction  
(2013) Drug squads: units specialised in drug law enforcement 
in Europe. Luxembourg: Publications Office of the European 
Union. https://www.drugsandalcohol.ie/21060/ 
2 European Monitoring Centre for Drugs and Drug Addiction  
(2017) Drug squads: units specialised in drug law enforcement in 
Europe. Situation in the EU member states, Norway and Turkey 
in 2015. Luxembourg: Publications Office of the European Union. 
https://www.drugsandalcohol.ie/28340/
Changes in the mandates of drug squads
• Technical mandates and terminology: Mainly, across 
European countries, technical aspects of drug law 
enforcement are not standardised. Notably, little or no 
changes have occurred since 2012. In addition, there are 
disparities in the type of terminology that is used.
• Territorial mandates: This refers to the ‘jurisdiction 
within which the responsibility and operations of a drug 
squad extend’ (p. 7). Drug squads can be assigned to one 
of four types: international, national, regional, and local. 
No major changes were shown since 2012.
• Drug law enforcement functions: The majority of drug 
law enforcement units (n=26) fulfil their technical 
mandates utilising multiple functionality (p. 9): 
 –  Case management, which refers to evidence that is 
provided to the prosecution. 
 –  Intelligence management, which refers to the process 
involved in obtaining and processing of information and 
how it is made available to law enforcement. 
 –  Operations, which refers to all overt and covert 
operations that aim to reduce drug supply. 
Limitations
A number of limitations have been identified. For example, 
figures for staff assigned to drug units need to be interpreted 
with caution as it is likely that some countries may have 
under-reported the total number of staff. Moreover, others 
that reported officers and total staff pointed out that an 
unknown number of these worked full-time in this area.
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UPDATES
Recent publications
The following abstracts are cited from published journal 
articles recently added to the repository of the HRB National 
Drugs Library at www.drugsandalcohol.ie 
PREVALENCE AND CURRENT SITUATION
Trends in injector deaths in Ireland, as recorded by the 
National Drug-Related Deaths Index, 1998–2014
Lynn T, Lynn E, Keenan E and Lyons S (2018)  
J Stud Alcohol Drugs, 79(2): 286–292.  
https://www.drugsandalcohol.ie/28728/ 
The purpose of this study was to provide trend analysis on all 
deaths among drug users who injected at or around the time 
of their death in Ireland between 1998 and 2014.
This study is the first to describe the trends in all deaths 
among drug users who injected at or around the time of 
their death in Ireland between 1998 and 2014. The analysis 
provides empirical evidence that can be used by policy 
makers to support the ongoing improvement of drug 
treatment services, harm reduction initiatives, and overdose 
prevention strategies for people who inject drugs.
‘Bury don’t discuss’: the help-seeking behaviour of family 
members affected by substance-use disorders
McDonagh D, Connolly N and Devaney C (2018)  
Child Care in Practice, Early online. 
https://www.drugsandalcohol.ie/28867/ 
This paper focuses on the help-seeking behaviour of those 
affected by substance use within their families, exploring the 
ways in which informal, semi-formal and formal supports are 
drawn on. The prohibitive factors and barriers influencing 
decision making by families in need is also discussed. Through 
a qualitative research approach this study collates the 
perspectives of a cohort of family members in Ireland, with 
a view to informing and enhancing the design and delivery 
of support services. While participants positively endorsed 
most forms of formal support, services were sought and 
accessed in an ad-hoc fashion, with a range of psychological, 
geographical and emotional barriers presenting.
The availability of services and the stigma associated with 
having family members affected by substance-use disorders 
are also highlighted. The paper provides opportunities and 
recommendations for potential ways of overcoming such 
barriers in order to access family support at an earlier stage.
Benzodiazepine and Z-drug prescribing in Ireland: analysis 
of national prescribing trends from 2005 to 2015
Cadogan CA, Ryan C, Cahir C, Bradley CP and Bennett K (2018) 
Br J Clin Pharmacol, 84(6): 1354–63. 
https://www.drugsandalcohol.ie/28750/ 
The aim of this study was to examine prescribing trends for 
benzodiazepines and Z-drugs to General Medical Services 
(GMS) patients in Ireland. 
Benzodiazepine prescribing to the GMS population in 
Ireland significantly decreased from 2005 to 2015, and was 
coupled with significant increases in Z-drug prescribing. The 
study shows that benzodiazepine and Z-drug prescribing is 
common in this population, with a third receiving long-term 
prescriptions. Targeted interventions are needed to reduce 
potentially inappropriate long-term prescribing and use of 
these medications in Ireland.
Presentations and preceding factors of drug overdose 
amongst adolescents admitted to a large regional hospital
Maduemem KE, Adedokun C and Umana E (2018)  
Ir Med J, 111(4). 
https://www.drugsandalcohol.ie/28870/ 
Suicide is the third most common cause of death among 
adolescents globally, and poisoning is the leading method 
of attempted suicide. Survival after self-poisoning or drug 
overdose (OD) is common, providing an opportunity for 
secondary prevention. The aim of this study was to highlight 
pattern of presentations and preceding factors of OD in an 
adolescent population. We retrospectively evaluated the 
data of 85 adolescents presenting to a large regional hospital 
with OD over a 3-year period. The female-to-male ratio 
was 4.3:1. The median age of adolescents was 15.83 (range: 
11.32–16.98) years. History of deliberate self-harm (DSH) 
was documented in 44.7%. Twenty-eight (33%) patients 
had been under the care of the CAMHS prior to index 
admission. Acetaminophen was the commonest drug used. 
Depression was the most common cause of mental illness in 
the study group. Substance abuse and conduct disorder were 
significantly commoner in males (p<0.05). Self-poisoning 
including OD in adolescence is a strong predictor of suicide; 
understanding the probable triggers can be significant in 
establishing appropriate prevention strategies.
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Acute hospital reconfiguration and self-harm  
presentations: a before-and-after study
Griffin E, Murphy C, Perry IJ, Lynch B,  
Arensman E and Corcoran P (2018)  
Ir J Med Sci, Early online. 
https://www.drugsandalcohol.ie/28777/ 
We assessed the impact of the reconfiguration of acute 
services within a hospital group in terms of the number and 
clinical management of self-harm presentations.
There is evidence to suggest that acute hospital 
reconfiguration of hospital services impacts on patterns 
of patient flow. Findings have implications for those 
implementing reconfiguration of acute services.
Survival from alcoholic hepatitis has not  
improved over time
Hughes E, Hopkins L and Parker R (2018)  
PLoS ONE, 13(2): e0192393. 
https://www.drugsandalcohol.ie/28817/ 
We aimed to describe changes in survival in alcoholic 
hepatitis (AH) over time by examining published data.
There has been no improvement in mortality from AH.  
This is not explained by changes in severity of disease.  
This emphasises the urgent need for effective treatments  
for this alcoholic hepatitis.
The impact of the Great Recession on the Irish drug market
Windle J (2017) Criminol Crim Justice, Early online. 
https://www.drugsandalcohol.ie/28797/ 
This article analyses 10 years (2004–2014) of An Garda 
Síochána controlled drug data to investigate the impact of 
economic recession and globalization on the Irish illicit drug 
market. The limited international literature on recessions 
and drug markets suggests that economic downturns can 
increase both drug consumption and dealing. Gardaí data 
may, however, suggest that the 2008 Great Recession 
reduced drug use and dealing, yet increased the cultivation 
and manufacture of drugs: trends which largely conflict with 
the international literature. Two testable hypotheses are 
drawn from the data: (1) net consumption and trade of illicit 
drugs were reduced by emigration triggered by the Great 
Recession; (2) the Great Recession forced an adaptation 
in the market which sped up the process towards import 
substitution of cannabis cultivation. The article concludes 
by investigating how recent changes highlight the globalized 
nature of Irish drug markets before proposing avenues for 
further research.
Making the invisible visible: masculinities and  
men’s illicit recreational drug use
Darcy C (2018) Irish Journal of Sociology, 26(1): 5–24.  
https://www.drugsandalcohol.ie/28662/ 
This paper highlights a significant gender disparity within 
Ireland’s illicit drug landscape, which is predominantly 
composed of men. Irish men’s historical gender invisibility 
contributed to their predominance as drug users being 
overlooked. Thus, this paper focuses a masculinities lens on 
Irish men’s recreational use of illicit drugs, making their drug 
taking visible as a gendered activity. 
The study reveals masculinities are an interpretative lens 
employed by men when trying to understand their own or 
other men’s drug taking. It is argued that men’s drug taking 
and masculinities intersect. In homosocial contexts, men’s 
recreational use of illicit drugs can contribute to them 
demonstrating masculinities to other drug-taking men; 
however, outside of these contexts, the same behaviours can 
be viewed by non-drug takers as emasculating.
Frequently used drug types and alcohol involvement  
in intentional drug overdoses in Ireland: a national  
registry study
Daly C, Griffin E, Ashcroft DM, Webb RT,  
Perry IJ and Arensman E (2018)  
Eur J Public Health, 28(4): 681–686. 
https://www.drugsandalcohol.ie/28709/ 
We aimed to determine the profile of patients engaging 
in overdose, to identify drugs frequently used and to 
quantify the contributions of multiple drug use and alcohol 
involvement.
People who engage in IDO frequently take prescription only 
or sales restricted drugs, often involving alcohol and/or 
multiple drug use. These findings highlight the importance of 
addressing drug and alcohol misuse, potential inappropriate 
prescribing and the enforcement of legislation restricting 
specific drug sales.
‘Blood letting’ – self-phlebotomy in injecting anabolic-
androgenic steroids within performance and image 
enhancing drug (PIED) culture
Brennan R, Wells J and Van Hout MC (2018)  
Int J Drug Policy, 55: 47–50.  
https://www.drugsandalcohol.ie/28680/ 
New evidence with regard to a previously undocumented 
practice — self-phlebotomy, known as 'bloodletting' — in 
contemporary injecting performance and image enhancing 
drug (PIED) culture is the subject of this paper. While self 
phlebotomy has been evidenced in psychiatric patients 
previously, it was performed here in people who inject AAS 
[anabolic-androgenic steroids] as a self-directed healthcare 
procedure.
This study is intended to provide the first snapshot of online 
communal activity around practice of self-phlebotomy or 
bloodletting amongst people who inject AAS. Further research 
in this area is warranted, and will be of benefit to healthcare 
workers, treatment providers and policy makers particularly as 
this relates to evidence informed and targeted harm reduction 
policies and effective public health interventions.
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Intentional drug overdose involving pregabalin and 
gabapentin: findings from the National Self-Harm  
Registry Ireland, 2007–2015
Daly C, Griffin E, Ashcroft DM, Webb RT,  
Perry IJ and Arensman E (2017)  
Clin Drug Invest, 38(4): 373–380. 
https://www.drugsandalcohol.ie/28436/ 
This paper examines the trends in the prevalence of 
gabapentinoids taken in intentional drug overdoses (IDO),  
the profile of individuals taking them, and associated 
overdose characteristics.
This study identified the increasing use of gabapentinoids 
in IDO, describing the profile and overdose characteristics 
of presentations. It is important for clinicians to exercise 
vigilance while prescribing gabapentinoids, including 
being aware of other medications that their patients may 
have access to. Our findings support the need for routine 
monitoring for signs of misuse among those prescribed 
gabapentinoids.
Microsystems of recovery in homeless services:  
the influence of service provider values on service  
users’ recovery experiences
Manning RM and Greenwood RM (2018)  
Am J Community Psychol, 61(1–2): 88–103.  
https://www.drugsandalcohol.ie/28449/ 
In the present mixed-methods study, the relationship of 
service providers’ work-related values to their service users’ 
recovery experiences in the microsystem of homelessness 
were examined. Findings confirm that providers’ values are 
an important influence on service users’ recovery. Results 
are discussed in terms of their implications for recovery-
oriented theory and practice.
Health and social problems associated with recent novel 
psychoactive substance (NPS) use amongst marginalised, 
nightlife and online users in six European countries
Van Hout MC, Benschop A, Bujalski M, Dabrowska K, 
Demetrovics Z, Felvinczi K, et al. (2017)  
Int J Ment Health Addict, 6(2): 480–95. 
https://www.drugsandalcohol.ie/28500/ 
The study describes health and social consequences of 
recent NPS use as reported in a survey of marginalised, 
nightlife and online NPS users in the Netherlands, Hungary, 
Portugal, Ireland, Germany and Poland (n=3023).
Marginalised users reported substantially more acute side 
effects, more mid- and long-term mental and physical 
problems, and more social problems. Development of 
country-specific NPS awareness raising initiatives, health and 
social service needs assessments, and targeted responses 
are warranted.
Evidence from qualitative studies of youth about the 
impacts of tobacco control policy on young people in 
Europe: a systematic review
Papanastasiou N, Hill S and Amos A (2018)  
Nicotine Tob Res, Early online. 
https://www.drugsandalcohol.ie/28488/ 
We reviewed existing qualitative evidence on young  
people and smoking in Europe in order to assess whether, 
in what ways and why young people comply with, adapt 
to, resist or circumvent tobacco control policies in their 
respective countries.
There is very little qualitative evidence exploring the  
impacts of tobacco control on youth smoking in Europe.  
To develop more effective smoking prevention policies that 
take account of local political, social and cultural contexts, 
more qualitative research from a wider range of European 
countries is needed in order to understand how tobacco 
control impacts on young people’s social worlds and smoking 
behaviours.
Self-harm among the homeless population in Ireland:  
a national registry-based study of incidence and  
associated factors
Barrett P, Griffin E, Corcoran P, O’Mahony M  
and Arensman E (2018)  
J Affect Disord, 229: 523–31.  
https://www.drugsandalcohol.ie/28457/ 
The study aim was to estimate the incidence of self-harm 
among the homeless population and to assess factors 
associated with self-harm.
The study only reflects self-harm presenting to hospital, 
and assumes no change in homelessness status after index 
presentation. Residual confounding may affect the results.
There is a disproportionate burden of self-harm among the 
homeless. Targeted preventive actions are warranted.
Traumatic brain injury and co-occurring problems  
in prison populations: a systematic review
O’Rourke C, Linden MA, Lohan M and Bates-Gaston J (2016) 
Brain Inj, 30(7): 839–54. 
https://www.drugsandalcohol.ie/28446/ 
The aim of this review is to systematically explore the 
literature surrounding the rates of traumatic brain injury (TBI) 
and their co-occurrences in a prison population.
The high degree of variation in TBI rates may be attributed 
to the inconsistent way in which TBI was measured, with 
only seven studies using valid and reliable screening tools. 
Additionally, gaps in the literature surrounding personality 
outcomes in prisoners with TBI, female prisoners with TBI 
and qualitative outcomes were found.
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Recent publications continued
The associations among personality, alcohol-related 
Protective Behavioural Strategies (PBS), alcohol 
consumption and sexual intercourse in Irish,  
female college students
Moylett S and Hughes BM (2017) Addict Behav Rep, 6: 56–64. 
https://www.drugsandalcohol.ie/28433/ 
The study presented one of the first examinations of the 
associations among personality, alcohol-related protective 
behavioural strategies (PBS), alcohol consumption, sexual 
intercourse and sex-related alcohol negative consequences 
in Irish, female college students (n=522).
The findings of this study posited that the use of PBS  
has a key role to play in the levels of sexual intercourse  
and alcohol consumption, age and openness, and the 
associated negative sexual consequences in Irish, female 
college students.
Is problem alcohol use being detected and treated  
in Irish general practice?
O’Regan A, Cullen W, Hickey L, Meagher D and Hannigan A 
(2018) BMC Fam Pract, 19(1): 30. 
https://www.drugsandalcohol.ie/28595/ 
The aims of this study were to investigate the prevalence of 
documentation of problem alcohol use in patient records in 
Irish general practice, and to describe the documentation of 
its diagnosis and treatment.
This is the first large scale study of patient records in general 
practice in Ireland looking at documentation of screening 
and treatment of problem alcohol use. It highlights the 
current lack of documentation of alcohol problems and the 
need to re-inforce positive attitudes among GPs in relation 
to preventive work.
A longitudinal qualitative analysis of the lived experience  
of the recovery process in opioid-dependent patients  
post-detoxification
Ivers JH, Larkan F and Barry J (2018)  
J Psychoactive Drugs, 50(3): 231–39.  
https://www.drugsandalcohol.ie/28586/ 
The aim of the study was to gain an in-depth understanding 
of opioid-dependent patients’ lived experiences post-
detoxification.
Recovery was seen as a process that was not always linear, 
and lapse and relapse were viewed as part of this process. 
Patients had great insight into ’risk factors for relapse’, 
information and knowledge gained over several years 
and many treatment episodes. Furthermore, the findings 
illustrate the role insight plays in any learning and growth 
experience and the emphasis that is placed upon it within 
the treatment journey; insight is a fundamental underpinning 
to any real growth and development. The current article 
argues that insight merits a more explicit role in the model of 
recovery capital.
Health and social care workers’ perceptions of NPS use in 
Northern Ireland
Campbell A, O’Neill N and Higgins K (2017)  
Int J Drug Policy, 40: 93–101.  
https://www.drugsandalcohol.ie/28564/ 
Due to the recent emergence of NPS and rapidly changing 
nature of the market, evidence about the way in which 
the emerging drugs are managed in health and social care 
settings is limited.
Study respondents reported that addressing NPS related 
issues with service users was a key aspect of their daily role 
and function. Levels of injecting behaviours were also viewed 
as relatively high by study participants. Almost all workers 
used harm reduction as their primary approach when 
working with service users and the majority of respondents 
called for additional practical training in relation to 
addressing drug interactions and intervening with NPS 
related issues.
Same crime: different punishment? Investigating  
sentencing disparities between Irish and non-Irish  
nationals in the Irish criminal justice system
Brandon AM and O’Connell M (2017)  
Br J Criminol, azx080, Early online. 
https://www.drugsandalcohol.ie/28629/ 
This exploratory study examines whether disparities exist 
between the sentencing of Irish and non-Irish defendants, 
using data from the Irish Prison Service.
Non-Irish nationals were statistically significantly under-
represented in the offence categories, ‘attempted robbery’, 
‘vehicle theft’, ‘criminal damage’, ‘robbery’, ‘parking fine 
offences’, ‘assault causing harm’, ‘intoxication in a public 
place’, ‘threatening behaviour in a public place’, ‘unlawful 
possession of drugs’ and ‘no television licence’. They were 
statistically significantly over-represented in the offence 
categories, ‘driving under the influence’, ‘no vehicle 
insurance’, ‘theft’ and ‘possession of drugs for sale/supply 
(to the value of <€13,000)’.
Drug affordability–potential tool for comparing illicit  
drug markets
Groshkova T, Cunningham A, Royuela L, Singleton N,  
Saggers T and Sedefov R (2018)  
Int J Drug Policy, 56: 187–196. 
https://www.drugsandalcohol.ie/28619/ 
This paper reviews some conceptual issues and 
measurement challenges relevant to the interpretation of 
price data. It also highlights the issues with between-country 
comparisons of drug prices and introduces the concept of 
affordability of drugs, going beyond purity-adjustment to 
account for varying national economies.
It is argued that purity-adjusted price alone provides an 
incomplete comparison of retail price across countries. The 
proposed new method takes account of the differing economic 
conditions within European countries, thus providing a more 
sophisticated tool for cross-national comparisons of retail drug 
markets in Europe. Future work will need to examine other 
potential uses of the drug affordability tool.
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A cost-effectiveness analysis of school-based suicide 
prevention programmes
Ahern S, Burke LA, McElroy B, Corcoran P, McMahon EM, Keeley 
H, et al. (2018) Eur Child Adolesc Psychiatry, Early online.  
https://www.drugsandalcohol.ie/28585/ 
We aimed to conduct a full cost-effectiveness analysis (CEA) 
of the large pan-European school-based RCT, Saving and 
Empowering Young Lives in Europe (SEYLE). 
This CEA supports YAM [Youth Aware of Mental Health] as the 
most cost-effective of the SEYLE interventions in preventing 
both a suicide attempt and severe suicidal ideation.
Attitudes of Irish patients with chronic pain towards  
medicinal cannabis
Rochford C, Edgeworth D, Hashim M and Harmon D (2018)  
Ir J Med Sci, Early online.  
https://www.drugsandalcohol.ie/28551/ 
The aim of this study was to evaluate the attitudes of Irish 
patients with chronic pain towards medicinal cannabis.
The study highlights the attitudes of chronic pain patients in 
Ireland towards medicinal cannabis. It shows their desire to have 
medical cannabis legalised for chronic pain and that they view it 
as a reasonable pain management option.
RESPONSES
Recommended next care following hospital-treated  
self-harm: patterns and trends over time
Arensman E, Griffin E, Daly C, Corcoran P,  
Cassidy E and Perry IJ (2018)  
PLoS ONE, 13(3): e0193587. 
https://www.drugsandalcohol.ie/28690/ 
The specific objectives of this study were to examine 
variation in the care of self-harm patients in hospital 
settings and to identify the factors that predict 
recommended next care following self-harm.
The extensive hospital variation in recommended next care 
indicates that management of self-harm patients may be 
determined more by where they present than by the needs 
of the patient. The study outcomes underline the need to 
standardise the clinical management of self-harm patients in 
general hospital settings.
The potential of neuroimaging for identifying predictors of 
adolescent alcohol use initiation and misuse
O’Halloran L, Nymberg C, Jollans L,  
Garavan H and Whelan R (2017)  
Addiction, 112(4): 719–26.  
https://www.drugsandalcohol.ie/28642/ 
We outline how neuroimaging data can identify the neural 
predictors of adolescent alcohol-use initiation and misuse 
by using prospective longitudinal studies to follow initially 
alcohol-naive individuals over time and by neuroimaging 
adolescents with inherited risk factors for alcohol misuse.
Neuroimaging predictors of alcohol use have shown modest 
utility to date. Future research should use out-of-sample 
performance as a quantitative measure of a predictor's 
utility. Neuroimaging data should be combined across 
multiple modalities, including structural information such 
as volumetrics and cortical thickness, in conjunction 
with white-matter tractography. A number of relevant 
neurocognitive systems should be assayed; particularly, 
inhibitory control, reward processing and executive 
functioning. Combining a rich magnetic resonance imaging 
data set could permit the generation of neuroimaging risk 
scores, which could potentially yield targeted interventions.
Boxing and substance use rehabilitation: building skills  
and capacities in disadvantaged communities
Morton S, O’Brien K and O’Reilly L (2018)  
Community Dev J, Early online. 
https://www.drugsandalcohol.ie/28721/ 
This paper considers the role of boxing training and 
mentoring in the context of the change processes for 
participants engaging in a twenty-week community based 
integrated fitness and education substance use rehabilitation 
programme.
The positive attributes associated with the ‘boxer’ identity 
has the potential to provide an alternative to ‘the addict’ 
identity within socially disadvantaged communities. It 
is argued that the boxing gym, particularly when nested 
within a range of educational and emotional supports, can 
become an empowering setting within a community. The 
coaching approach has the potential to challenge gendered 
norms in relation to sport and fitness, while also supporting 
participants to utilize their physical bodies with intent and 
focus. The inclusion of programme mentors is an important 
consideration for substance use rehabilitation programmes, 
especially within communities characterized by exclusion 
and isolation.
POLICY
Impact of tobacco control policies on smoking prevalence and 
quit ratios in 27 European Union countries from 2006 to 2014
Feliu A, Filippidis FT, Joossens L, Fong GT, Vardavas CI,  
Baena A, et al. (2018)  
Tob Control, Early online. 
https://www.drugsandalcohol.ie/28618/ 
The aim of this paper was to assess the midterm association 
of tobacco control policies on smoking prevalence and quit 
ratios among 27 European Union (EU) Member States (EU27).
EU27 should continue implementing comprehensive tobacco 
control policies as they are key for reducing the prevalence 
of smoking and an increase in tobacco cessation rates in 
their population.
